Technoprobe Aktienkurs
Ist Technoprobe eine Topscorer-Aktie nach der Dividenden-, High-Growth-Investing- oder Levermann-Strategie?
Als kostenloser aktien.guide Basis-Nutzer kannst Du die Scores zu allen 9.090 weltweiten Aktien einsehen.
aktien.guide Premium
aktien.guide Unlimited
Kennzahlen
📘 Marktkapitalisierung
📈 Was ist das?
Die Marktkapitalisierung zeigt, wie viel ein Unternehmen laut Börse aktuell wert ist.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Sie hilft Unternehmen in Größenklassen (Large, Mid, Small Cap) einzuordnen und gibt Hinweise auf Marktmacht und Stabilität.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Große Unternehmen gelten als stabiler, zahlen oft Dividenden, wachsen aber langsamer.
- Kleine Firmen können stärker wachsen, sind aber schwankungsanfälliger.
- Die Marktkapitalisierung ist ein guter Indikator für Unternehmensgröße, aber kein Maß für Unter- oder Überbewertung.
📘 Enterprise Value (Unternehmenswert)
📈 Was ist das?
Der Enterprise Value (EV) zeigt, was ein Unternehmen tatsächlich kostet, wenn man es komplett übernehmen würde – inklusive Schulden und abzüglich Cash.
🧮 Wie wird es berechnet?
(= Marktkapitalisierung + Nettoverschuldung)
🏛️ Wofür ist es wichtig?
Der EV ist eine realistischere Bewertungsbasis als die Marktkapitalisierung, da er die Kapitalstruktur berücksichtigt. Er ist Grundlage für Kennzahlen wie EV/FCF oder EV/Sales.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Der Enterprise Value zeigt, was ein Unternehmen tatsächlich wert ist – unabhängig davon, wie es finanziert ist.
- Er ist besonders wichtig für professionelle Investoren, da er eine objektivere Grundlage für Bewertungsvergleiche bietet als die Marktkapitalisierung allein.
- Ein Unternehmen mit hoher Verschuldung erscheint im EV teurer, eines mit viel Cash günstiger – auch wenn sie an der Börse gleich viel wert sind.
📘 Nettoverschuldung
📈 Was ist das?
Die Nettoverschuldung zeigt, wie viele Schulden nach Abzug des verfügbaren Cashs tatsächlich verbleiben.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Sie zeigt, wie stark ein Unternehmen von Fremdkapital abhängig ist – und wie gut es in der Lage ist, seine Schulden kurzfristig zu bedienen.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Eine niedrige oder negative Nettoverschuldung bedeutet hohe finanzielle Stabilität.
- Unternehmen mit viel Cash und geringer Verschuldung sind besser gerüstet für Krisen.
- Eine hohe Nettoverschuldung erhöht das Risiko – besonders bei steigenden Zinsen oder konjunkturellen Schwächen.
📘 Cash
📈 Was ist das?
Der Cashbestand zeigt, wie viele liquide Mittel einem Unternehmen sofort zur Verfügung stehen.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Er gibt Auskunft über die finanzielle Flexibilität: Ein hoher Cashbestand ermöglicht Investitionen, Rückkäufe oder Krisenresistenz.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Ein hoher Cashbestand zeigt finanzielle Stärke und Handlungsspielraum.
- Cash kann für Investitionen, Schuldentilgung oder Aktienrückkäufe genutzt werden.
- Allerdings: Zu viel ungenutztes Kapital kann auch auf mangelnde Investitionsideen hinweisen.
📘 Anzahl ausstehender Aktien
📈 Was ist das?
Die Anzahl ausstehender Aktien gibt an, wie viele Aktien eines Unternehmens aktuell im Umlauf sind und von Investoren gehalten werden.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Sie ist die Grundlage für viele Kennzahlen wie Gewinn je Aktie (EPS), Marktkapitalisierung oder KGV.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Je weniger Aktien im Umlauf sind, desto höher fällt z. B. der Gewinn je Aktie aus – wichtig für Bewertung und Dividendenrendite.
- Aktienrückkäufe verringern die Anzahl ausstehender Aktien – und steigern den Wert je Aktie.
- Kapitalerhöhungen haben den gegenteiligen Effekt: mehr Aktien → Verwässerung der bestehenden Anteile.
📘 Kurs-Gewinn-Verhältnis (KGV)
📈 Was ist das?
Das KGV zeigt, wie oft der Gewinn pro Aktie im aktuellen Aktienkurs enthalten ist – also wie „teuer“ eine Aktie im Verhältnis zum Gewinn ist.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Das KGV gehört zu den bekanntesten Bewertungskennzahlen. Es hilft Anlegern einzuschätzen, ob eine Aktie im Vergleich zu ihrem Gewinn eher günstig oder teuer erscheint.
🧮 Berechnung
📊 KGV (TTM) = bezogen auf den Gewinn der letzten 12 Monate (Trailing Twelve Months):🎯 Was bedeutet das für Anleger?
- Ein niedriges KGV kann auf eine günstige Bewertung hindeuten – oder auf Probleme im Geschäftsmodell.
- Ein hohes KGV kann Wachstumserwartungen widerspiegeln – oder eine überbewertete Aktie.
📘 Kurs-Umsatz-Verhältnis (KUV)
📈 Was ist das?
Das KUV zeigt, wie viel Anleger für 1 € Umsatz eines Unternehmens zahlen – unabhängig vom Gewinn.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Das KUV ist besonders bei wachstumsstarken oder noch nicht profitablen Unternehmen hilfreich. Es zeigt, wie hoch der Umsatz an der Börse bewertet wird.
🧮 Berechnung
Marktkapitalisierung = 13,49 Mrd. € | Umsatz (TTM) = 766,57 Mio. €
Marktkapitalisierung = 13,49 Mrd. € | Umsatz erwartet = 1,11 Mrd. €
🎯 Was bedeutet das für Anleger?
- Ein niedriges KUV kann auf Unterbewertung hindeuten – oder auf schwache Margen.
- Ein hohes KUV kann hohe Erwartungen widerspiegeln – oder übermäßigen Optimismus.
- Besonders sinnvoll bei Wachstumsunternehmen, bei denen der Gewinn oder Free Cashflow (noch) keine Aussagekraft hat.
📘 Unternehmenswert zu Umsatz (EV/Sales)
📈 Was ist das?
EV/Sales zeigt, wie viel Anleger für 1 € Umsatz eines Unternehmens zahlen, wenn man auch Schulden und Cash berücksichtigt – es ist eine kapitalstrukturbereinigte Version des KUV.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Diese Kennzahl eignet sich besonders für den Vergleich von Unternehmen mit unterschiedlicher Verschuldung – sie zeigt, wie teuer ein Unternehmen tatsächlich im Verhältnis zum Umsatz ist.
🧮 Berechnung
Enterprise Value = 12,81 Mrd. € | Umsatz (TTM) = 766,57 Mio. €
Enterprise Value = 12,81 Mrd. € | Umsatz erwartet = 1,11 Mrd. €
🎯 Was bedeutet das für Anleger?
- EV/Sales ist neutral gegenüber der Kapitalstruktur und eignet sich gut für Unternehmensvergleiche.
- Ein niedriges Verhältnis kann auf eine günstig bewertete Aktie hindeuten – ein hohes Verhältnis auf hohe Erwartungen oder Überbewertung.
- Besonders nützlich bei wachstumsstarken, noch nicht profitablen Firmen.
📘 Unternehmenswert zu Free Cashflow (EV/FCF) | ex SBC
📈 Was ist das?
EV/FCF setzt den Unternehmenswert eines Unternehmens ins Verhältnis zu seinem Free Cashflow. Die Kennzahl zeigt damit, mit welchem Vielfachen des aktuellen Free Cashflows ein Unternehmen bewertet wird. EV/FCF ex SBC berücksichtigt zusätzlich aktienbasierte Vergütungen (Stock-Based Compensation, SBC). SBC verursacht zwar keinen direkten Cash-Abfluss, kann bestehende Aktionäre jedoch durch die Ausgabe zusätzlicher Aktien verwässern. Deshalb wird SBC bei dieser Variante vom Free Cashflow abgezogen.
🧮 Wie wird es berechnet?
EV/FCF ex SBC = Enterprise Value ÷ (Free Cashflow (TTM) − SBC)
🏛️ Wofür ist es wichtig?
EV/FCF ermöglicht eine Bewertung auf Basis des Free Cashflows und ergänzt damit gewinnbasierte Bewertungskennzahlen wie das KGV. Die Variante ex SBC berücksichtigt zusätzlich die wirtschaftliche Belastung durch aktienbasierte Vergütungen und ermöglicht dadurch eine konservativere Betrachtung aus Sicht der Aktionäre.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Ein niedriges EV/FCF bedeutet, dass der Unternehmenswert im Verhältnis zum aktuellen Free Cashflow niedrig ist. Die Ursachen dafür sollten jedoch immer im Unternehmens- und Branchenkontext betrachtet werden.
- Ein hohes EV/FCF bedeutet, dass der Unternehmenswert im Verhältnis zum aktuellen Free Cashflow hoch ist. Das kann beispielsweise auf hohe Wachstumserwartungen oder eine vorübergehend schwache Cash-Generierung zurückzuführen sein.
- Bei positiver SBC und positivem bereinigtem Free Cashflow fällt EV/FCF ex SBC in der Regel höher aus als das klassische EV/FCF.
- Besonders aussagekräftig ist die Kennzahl bei Unternehmen mit relativ stabilen und gut einschätzbaren Cashflows.
- Bei negativem oder sehr niedrigem Free Cashflow ist EV/FCF nur eingeschränkt aussagekräftig und sollte nicht wie ein gewöhnliches Bewertungsmultiple interpretiert werden.
📘 Kurs-Buchwert-Verhältnis (KBV)
📈 Was ist das?
Das KBV zeigt, wie hoch der Marktwert eines Unternehmens im Verhältnis zu seinem bilanziellen Eigenkapital ist.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Das KBV ist besonders bei Substanzwerten (z. B. Banken, Industrie) relevant. Es hilft Anlegern zu erkennen, ob ein Unternehmen unter oder über seinem buchhalterischen Vermögen bewertet ist.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Ein KBV unter 1 kann auf Unterbewertung oder schwache Rentabilität hindeuten.
- Ein KBV über 1 zeigt, dass der Markt dem Unternehmen Mehrwert über den Buchwert hinaus zuschreibt (z. B. Marken, Patente, Wachstum).
- Das KBV eignet sich besonders gut für Unternehmen mit stabilen, materiellen Vermögenswerten.
📘 Eigenkapitalquote
📈 Was ist das?
Die Eigenkapitalquote zeigt, wie hoch der Anteil des Eigenkapitals an der Bilanzsumme eines Unternehmens ist – also wie stark es sich aus eigenen Mitteln finanziert.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Eine hohe Eigenkapitalquote steht für finanzielle Stabilität, Krisenfestigkeit und gute Bonität. Sie ist besonders relevant bei der Beurteilung der Verschuldung.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Eine hohe Eigenkapitalquote signalisiert finanzielle Stabilität – besonders in Krisenzeiten.
- Ein niedriger Wert kann auf ein höheres Risiko oder eine aggressive Verschuldung hinweisen.
- Wichtig: Die Eigenkapitalquote sollte immer gemeinsam mit der Eigenkapitalrendite betrachtet werden. Nur so lässt sich beurteilen, ob ein Unternehmen nicht nur solide, sondern auch effizient wirtschaftet.
📘 Eigenkapitalrendite (ROE)
📈 Was ist das?
Die Eigenkapitalrendite zeigt, wie effizient ein Unternehmen mit dem Kapital seiner Aktionäre arbeitet – also wie viel Gewinn es pro Euro Eigenkapital erwirtschaftet.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Die Eigenkapitalrendite ist eine zentrale Rentabilitätskennzahl. Sie hilft Anlegern zu erkennen, ob das Unternehmen eine attraktive Verzinsung auf das eingesetzte Eigenkapital erwirtschaftet.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Eine hohe Eigenkapitalrendite spricht für ein starkes, effizientes Geschäftsmodell.
- Besonders interessant ist sie bei kapitalintensiven Firmen oder solchen mit hoher Eigenkapitalquote.
- Wichtig: Ein sehr hoher ROE kann auch auf hohe Schulden hinweisen – daher sollte sie immer im Kontext mit der Eigenkapitalquote betrachtet werden.
📘 Return on Capital Employed (ROCE)
📈 Was ist das?
ROCE misst die Gesamtrentabilität eines Unternehmens – also wie effizient es das eingesetzte Kapital (Eigen- und Fremdkapital) zur Gewinnerzielung nutzt.
🧮 Wie wird es berechnet?
Das eingesetzte Kapital ist das gesamte betriebsnotwendige Kapital, unabhängig von der Finanzierungsquelle.
🏛️ Wofür ist es wichtig?
ROCE eignet sich besonders gut für den Vergleich unterschiedlich finanzierter Unternehmen. Es zeigt, wie effektiv ein Unternehmen Kapital investiert – unabhängig von der Kapitalstruktur.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Ein hoher ROCE zeigt, dass ein Unternehmen sein Kapital effizient einsetzt – unabhängig davon, ob es durch Eigen- oder Fremdkapital finanziert ist.
- Je höher der ROCE im Vergleich zu ähnlichen Unternehmen, desto mehr Wert schafft das Unternehmen mit seinem investierten Kapital.
- Besonders wichtig ist der ROCE bei Firmen mit hohen Investitionen – z. B. in Industrie, Energie oder Infrastruktur.
📘 Return on Invested Capital (ROIC)
📈 Was ist das?
ROIC zeigt, wie effizient ein Unternehmen das Kapital investiert, das langfristig im operativen Geschäft gebunden ist – unabhängig davon, ob es aus Eigen- oder Fremdkapital stammt.
🧮 Wie wird es berechnet?
- NOPAT = „Net Operating Profit After Taxes“
- Investiertes Kapital = operatives Vermögen abzüglich nicht-verzinster Schulden
🏛️ Wofür ist es wichtig?
ROIC ist eine der präzisesten Kennzahlen zur Bewertung der Kapitalrendite – besonders im Vergleich zur Eigenkapitalrendite, weil es Verzerrungen durch Schulden vermeidet. Er zeigt, ob ein Unternehmen Mehrwert für alle Kapitalgeber schafft.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Ein hoher ROIC zeigt, wie gut ein Unternehmen mit dem tatsächlich investierten (betriebsnotwendigen) Kapital wirtschaftet.
- Im Unterschied zu ROCE wird nur Kapital betrachtet, das wirklich zur Finanzierung operativer Aktivitäten dient – und verzinst werden muss.
- Besonders hilfreich, um die Kapitalrendite von Unternehmen mit viel „überschüssigem“ Kapital oder zinsfreien Verbindlichkeiten realistisch zu vergleichen.
📘 Verschuldungsgrad (Leverage Ratio)
📈 Was ist das?
Der Verschuldungsgrad zeigt, wie stark ein Unternehmen durch verzinsliche Schulden (z. B. Kredite und Anleihen) im Verhältnis zum Eigenkapital finanziert ist.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Die Kennzahl hilft, das finanzielle Risiko und die Abhängigkeit von Fremdkapital zu beurteilen. Ein hoher Verschuldungsgrad kann die Eigenkapitalrendite steigern – birgt aber auch erhöhte Risiken bei Zinsanstiegen oder Liquiditätsengpässen.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Ein niedriger Verschuldungsgrad steht für finanzielle Stabilität und Unabhängigkeit.
- Ein hoher Wert kann auf erhöhte Risiken hinweisen – insbesondere bei schwankenden Zinsen oder konjunkturellen Schwächen.
- Wichtig: Immer im Kontext zur Branche und Kapitalintensität bewerten.
📘 Umsatz
📈 Was ist das?
Der Umsatz zeigt, wie viel ein Unternehmen insgesamt mit seinen Produkten und Dienstleistungen verdient – also den Bruttoerlös vor Abzug von Kosten.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Der Umsatz ist eine der zentralen Kennzahlen zur Einschätzung der Unternehmensgröße, Marktstellung und Wachstumskraft.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Ein wachsender Umsatz zeigt eine steigende Nachfrage und kann ein guter Frühindikator für Gewinnsteigerungen sein.
- Vergleiche von aktuellem und erwartetem Umsatz geben Hinweise auf das Marktumfeld und Analystenerwartungen.
- Wichtig: Starker Umsatz allein genügt nicht – auch Margen und Profitabilität zählen.
📘 EBITDA
📈 Was ist das?
EBITDA steht für „Earnings Before Interest, Taxes, Depreciation and Amortization“ – also Gewinn vor Zinsen, Steuern und Abschreibungen. Es zeigt das operative Ergebnis eines Unternehmens, bereinigt um bilanztechnische und finanzierungsbedingte Effekte.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
EBITDA ist eine verbreitete Kennzahl zur Beurteilung der operativen Leistungsfähigkeit – insbesondere bei kapitalintensiven Unternehmen oder im internationalen Vergleich.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Ein hohes oder wachsendes EBITDA spricht für starke operative Erträge – unabhängig von Bilanzierung oder Steuerlast.
- EBITDA ist besonders nützlich, um Unternehmen branchenübergreifend zu vergleichen.
- Wichtig: EBITDA ist keine offizielle Gewinnkennzahl – Abschreibungen und Finanzierungskosten werden ausgeklammert.
📘 EBIT
📈 Was ist das?
EBIT steht für „Earnings Before Interest and Taxes“ – also Gewinn vor Zinsen und Steuern. Es zeigt das operative Ergebnis eines Unternehmens nach Abschreibungen, aber vor Finanzierungs- und Steueraufwand.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
EBIT ist eine zentrale Kennzahl zur Beurteilung der Profitabilität aus dem Kerngeschäft – unabhängig von Kapitalstruktur oder Steuersystem.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Ein hohes EBIT deutet auf ein profitables Kerngeschäft hin – vor Zinslasten oder steuerlichen Effekten.
- Es erlaubt objektivere Vergleiche zwischen Unternehmen mit unterschiedlicher Finanzierung.
- Im Vergleich mit EBITDA zeigt EBIT bereits den Einfluss von Abschreibungen auf das operative Ergebnis.
📘 Nettogewinn
📈 Was ist das?
Der Nettogewinn ist der verbleibende Jahresüberschuss (oder -fehlbetrag) eines Unternehmens – nach Abzug aller Kosten, Steuern, Zinsen und Abschreibungen
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Der Nettogewinn ist die zentrale Erfolgskennzahl – er zeigt, wie profitabel ein Unternehmen nach allen Kosten tatsächlich arbeitet.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Ein steigender Nettogewinn zeigt, dass das Unternehmen effizient wirtschaftet – trotz aller Kosten.
- Die Entwicklung des Gewinns beeinflusst z. B. direkt das KGV und weitere Kennzahlen.
- Im Zeitverlauf lässt sich ablesen, wie stabil und profitabel ein Geschäftsmodell wirklich ist.
📘 Free Cashflow (FCF) | ex SBC
📈 Was ist das?
Der Free Cashflow gibt an, wie viel Bargeld tatsächlich übrig bleibt, nachdem ein Unternehmen seine Betriebsausgaben und Investitionsausgaben gedeckt hat. Der FCF ex SBC zieht zusätzlich die aktienbasierte Vergütung ab, um den Cashflow um den Effekt der nicht zahlungswirksamen SBC zu bereinigen.
🧮 Wie wird es berechnet?
Free Cashflow ex SBC = Operativer Cashflow − SBC − Investitionen in Sachanlagen (CAPEX)
🏛️ Wofür ist es wichtig?
Der FCF spiegelt die tatsächliche Finanzkraft eines Unternehmens wider – unabhängig von den bilanziellen Gewinnen. Er zeigt, wie viel Spielraum ein Unternehmen für Dividenden, Aktienrückkäufe oder den Schuldenabbau hat. Der FCF ex SBC zieht zusätzlich die aktienbasierte Vergütung ab und zeigt, wie hoch die Cash-Generierung nach Abzug der SBC ausfällt.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Ein hoher Free Cashflow bedeutet, dass ein Unternehmen echte Finanzkraft besitzt – unabhängig vom bilanzierten Gewinn.
- Er ist oft die solideste Grundlage für nachhaltige Dividenden und Aktienrückkäufe.
- Sinkender FCF kann ein Warnsignal sein – auch wenn der Gewinn stabil aussieht.
📘 Umsatzwachstum
📈 Was ist das?
Das Umsatzwachstum zeigt, wie stark sich die Erlöse eines Unternehmens im Vergleich zum Vorjahr verändert haben – tatsächlich (TTM) und auf Prognosebasis (erwartet).
🧮 Wie wird es berechnet?
Erwartet = (Umsatz erwartet ÷ Umsatz Vorjahr − 1) × 100
Erwartetes Wachstum basiert auf Analystenschätzungen für das laufende Geschäftsjahr.
🏛️ Wofür ist es wichtig?
Ein wachsender Umsatz ist ein zentrales Signal für steigende Nachfrage, Geschäftsausweitung und Marktanteilsgewinne – besonders bei Wachstumsunternehmen.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Wachstum ist der Motor langfristiger Wertsteigerung – besonders bei Technologie- und Wachstumsaktien.
- Wichtig ist nicht nur das aktuelle Wachstum, sondern auch dessen Nachhaltigkeit.
- Prognosen zeigen, ob Analysten weiteres Potenzial erwarten – oder eine Verlangsamung.
📘 EBITDA-Wachstum
📈 Was ist das?
Das EBITDA-Wachstum zeigt, wie stark das operative Ergebnis eines Unternehmens vor Zinsen, Steuern und Abschreibungen im Vergleich zum Vorjahr gestiegen oder gesunken ist.
🧮 Wie wird es berechnet?
Erwartet = (erwartetes EBITDA ÷ EBITDA Vorjahr − 1) × 100
Erwartetes Wachstum basiert auf Analystenschätzungen für das laufende Geschäftsjahr.
🏛️ Wofür ist es wichtig?
Ein steigendes EBITDA ist ein Zeichen für verbesserte operative Ertragskraft – unabhängig von Finanzierungsstruktur oder Abschreibungen.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Starkes EBITDA-Wachstum signalisiert operative Effizienz und Skalierung – besonders relevant in Wachstumsphasen.
- EBITDA-Wachstum ist ein Frühindikator für Margen- und Gewinnentwicklung – sollte aber stets im Zusammenhang mit Umsatz und EBIT betrachtet werden.
📘 EBIT Wachstum
📈 Was ist das?
Das EBIT-Wachstum zeigt, wie stark das operative Ergebnis eines Unternehmens (nach Abschreibungen, aber vor Zinsen und Steuern) im Vergleich zum Vorjahr gewachsen ist.
🧮 Wie wird es berechnet?
Erwartet = (erwartetes EBIT ÷ EBIT Vorjahr − 1) × 100
Erwartetes Wachstum basiert auf Analystenschätzungen für das laufende Geschäftsjahr.
🏛️ Wofür ist es wichtig?
Das EBIT-Wachstum ist ein direkter Indikator für die wirtschaftliche Entwicklung des operativen Geschäfts – unter Berücksichtigung der Kapitalintensität (Abschreibungen).
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Steigendes EBIT signalisiert wachsende operative Rentabilität – auch unter Berücksichtigung von Abschreibungen.
- Das EBIT-Wachstum ist ein wichtiges Maß zur Beurteilung von Geschäftsmodellen mit hohen Investitionskosten.
- Im Zusammenspiel mit Umsatz- und EBITDA-Wachstum ergibt sich ein umfassendes Bild zur operativen Entwicklung.
📘 Nettogewinn-Wachstum
📈 Was ist das?
Das Nettogewinn-Wachstum zeigt, wie stark der Jahresüberschuss eines Unternehmens gegenüber dem Vorjahr gestiegen oder gesunken ist – sowohl tatsächlich (TTM) als auch auf Basis von Prognosen (erwartet).
🧮 Wie wird es berechnet?
Erwartet = (erwarteter Nettogewinn ÷ Nettogewinn Vorjahr − 1) × 100
Der erwartete Wert basiert auf Analystenschätzungen für das laufende Geschäftsjahr.
🏛️ Wofür ist es wichtig?
Der Gewinn ist die entscheidende Ergebnisgröße für ein Unternehmen. Ein wachsender Nettogewinn deutet auf steigende Effizienz, stabile Kostenkontrolle und nachhaltige Ertragskraft hin.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Wachsender Nettogewinn stärkt die Bewertung, Dividendenfähigkeit und Kursfantasie.
- Stagnierender oder rückläufiger Gewinn trotz Umsatzwachstum kann auf Margendruck hinweisen.
📘 Free Cashflow-Wachstum
📈 Was ist das?
Das Free-Cashflow-Wachstum zeigt, wie sich der freie Mittelzufluss eines Unternehmens im Vergleich zum Vorjahr verändert hat – also der Betrag, der nach allen operativen Ausgaben und Investitionen übrig bleibt.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Free Cashflow ist der echte, verfügbare Geldzufluss. Wachstum in diesem Bereich ist ein Zeichen für finanzielle Stärke und steigende Flexibilität bei Dividenden, Rückkäufen oder Investitionen.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Sinkender Free Cashflow kann auf steigende Investitionen, höhere Kosten oder stagnierende operative Erträge hindeuten.
- Besonders bei Dividendenwerten ist das FCF-Wachstum wichtig – denn Dividenden werden letztlich aus dem verfügbaren Cash gezahlt.
- Ein negativer Trend sollte genauer analysiert werden – er ist nicht zwangsläufig schlecht, aber potenziell ein Warnsignal.
📘 Bruttomarge
📈 Was ist das?
Die Bruttomarge zeigt, wie viel vom Umsatz nach Abzug der direkten Herstellungskosten (Material, Produktion) als Bruttogewinn übrig bleibt – also der „Rohgewinn“ eines Unternehmens.
🧮 Wie wird es berechnet?
Auch: Bruttomarge = Bruttogewinn ÷ Umsatz × 100
🏛️ Wofür ist es wichtig?
Die Bruttomarge gibt Aufschluss über die Profitabilität eines Produkts oder Geschäftsmodells vor Fixkosten, Steuern und Zinsen. Sie zeigt, wie effizient ein Unternehmen produzieren oder einkaufen kann.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Eine hohe Bruttomarge deutet auf starke Preissetzungsmacht und effiziente Herstellung hin.
- Sinkende Bruttomargen können auf Kostensteigerungen oder Preisdruck hindeuten.
- Besonders im Vergleich zu Wettbewerbern liefert die Bruttomarge wertvolle Einblicke in die Geschäftsqualität.
📘 EBITDA-Marge
📈 Was ist das?
Die EBITDA-Marge zeigt, wie viel vom Umsatz als operativer Gewinn vor Zinsen, Steuern und Abschreibungen (EBITDA) übrig bleibt. Sie misst die operative Effizienz – ohne Verzerrungen durch Finanzierung oder Buchwerte.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Die EBITDA-Marge hilft zu verstehen, wie viel operativer Gewinn ein Unternehmen aus jedem Euro Umsatz erzielt – unabhängig von Kapitalstruktur oder steuerlichem Umfeld.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Eine hohe EBITDA-Marge zeigt starke operative Ertragskraft – unabhängig von Bilanzierungseffekten.
- Die Marge ermöglicht gute Vergleiche zwischen Unternehmen und Branchen.
- Ein stabiler oder wachsender Wert kann auf effiziente Kostenkontrolle und Skalierbarkeit hindeuten.
📘 EBIT-Marge
📈 Was ist das?
Die EBIT-Marge zeigt, wie viel Prozent des Umsatzes als operativer Gewinn nach Abschreibungen, aber vor Zinsen und Steuern übrig bleiben.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Die EBIT-Marge misst die operative Ertragskraft eines Unternehmens unter Berücksichtigung der Kapitalintensität (z. B. Maschinen, Anlagen). Sie eignet sich gut zum Vergleich von Geschäftsmodellen mit unterschiedlich hohen Abschreibungen.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Eine hohe EBIT-Marge zeigt, dass ein Unternehmen auch nach Abschreibungen effizient arbeitet.
- Sie ist besonders relevant in kapitalintensiven Branchen.
- Langfristig stabile oder steigende Margen sind ein Zeichen wirtschaftlicher Stärke und Preissetzungsmacht.
📘 Nettomarge
📈 Was ist das?
Die Nettomarge zeigt, wie viel vom Umsatz am Ende als „Reingewinn“ übrig bleibt – also nach Abzug aller Kosten, Zinsen, Steuern und Abschreibungen.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Die Nettomarge gibt an, wie effizient ein Unternehmen über alle Stufen hinweg wirtschaftet. Sie zeigt, wie viel Gewinn tatsächlich je Euro Umsatz übrig bleibt.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Eine hohe Nettomarge zeigt, dass ein Unternehmen nicht nur operativ stark ist, sondern auch seine Finanzierung und Steuerbelastung im Griff hat.
- Vergleiche mit Wettbewerbern geben Einblicke in die wirtschaftliche Qualität.
- Sinkende Nettomargen trotz Umsatzwachstum können ein Warnsignal sein – etwa für steigende Kosten oder sinkende Effizienz.
📘 Free-Cashflow-Marge | ex SBC
📈 Was ist das?
Die Free-Cashflow-Marge zeigt, wie viel Free Cashflow ein Unternehmen im Verhältnis zu seinem Umsatz erwirtschaftet. Der Free Cashflow entspricht vereinfacht dem operativen Cashflow abzüglich der Investitionsausgaben. Die Free-Cashflow-Marge ex SBC berücksichtigt zusätzlich aktienbasierte Vergütungen (Stock-Based Compensation, SBC). SBC verursacht zwar keinen direkten Cash-Abfluss, kann bestehende Aktionäre jedoch durch die Ausgabe zusätzlicher Aktien verwässern. Daher wird SBC bei dieser Kennzahl vom Free Cashflow abgezogen.
🧮 Wie wird es berechnet?
Free-Cashflow-Marge ex SBC = (Free Cashflow − SBC) ÷ Umsatz × 100
🏛️ Wofür ist es wichtig?
Die Free-Cashflow-Marge zeigt, wie effizient ein Unternehmen seinen Umsatz in Free Cashflow umwandelt. Ein hoher Free Cashflow kann dem Unternehmen finanziellen Spielraum für Dividenden, Aktienrückkäufe, Schuldentilgung oder weitere Investitionen geben. Die Variante ex SBC berücksichtigt zusätzlich die wirtschaftliche Belastung durch aktienbasierte Vergütungen und ermöglicht dadurch eine konservativere Betrachtung der Cash-Generierung aus Sicht der Aktionäre.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Eine hohe Free-Cashflow-Marge zeigt, dass ein Unternehmen einen hohen Anteil seines Umsatzes in Free Cashflow umwandelt.
- Das kann dem Unternehmen mehr finanziellen Spielraum für Dividenden, Aktienrückkäufe, Schuldentilgung oder Investitionen geben.
- Die Free-Cashflow-Marge ex SBC berücksichtigt zusätzlich die mögliche Verwässerung durch aktienbasierte Vergütungen.
- Besonders aussagekräftig ist die Entwicklung über mehrere Jahre. Sinkende Werte können beispielsweise auf höhere Investitionen, Veränderungen im Working Capital oder eine schwächere operative Entwicklung zurückzuführen sein.
📘 Ergebnis je Aktie (EPS)
📈 Was ist das?
Das Ergebnis je Aktie (EPS) zeigt, wie viel Gewinn auf eine einzelne Aktie entfällt – und ist eine der wichtigsten Kennzahlen zur Bewertung von Unternehmen.
🧮 Wie wird es berechnet?
Die verwässerte Aktienanzahl berücksichtigt auch potenzielle neue Aktien, etwa durch Optionen, Wandelanleihen oder andere Umtauschrechte.
🏛️ Wofür ist es wichtig?
EPS bildet die Basis für viele Bewertungskennzahlen wie KGV, PEG oder Payout Ratio. Es macht den Gewinn für Aktionäre vergleichbar – unabhängig von der Unternehmensgröße.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- EPS hilft, die Profitabilität pro Aktie zu erfassen – und ist besonders wichtig im Zeitvergleich oder im Vergleich mit Analystenschätzungen.
- Steigendes EPS kann ein Zeichen für stabiles Wachstum oder Aktienrückkäufe sein.
- Wichtig: Verwende verwässertes EPS für realistische Bewertungen – besonders bei stark aktienbasierten Vergütungssystemen.
📘 Free Cashflow je Aktie (FCF je Aktie)
📈 Was ist das?
Der Free Cashflow je Aktie zeigt, wie viel freier Mittelzufluss einem Unternehmen pro Aktie zur Verfügung steht – nach Investitionen, aber vor Dividenden oder Schuldentilgung.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Der FCF je Aktie zeigt, wie viel liquide Mittel pro Aktie tatsächlich im Unternehmen verbleiben – wichtig für Dividenden, Aktienrückkäufe oder Schuldentilgung. Im Gegensatz zum Gewinn ist er schwerer manipulierbar und daher besonders aussagekräftig.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Ein hoher Free Cashflow je Aktie ist ein Zeichen für hohe finanzielle Flexibilität.
- Er zeigt, wie viel Kapital ein Unternehmen effektiv einsetzen oder ausschütten kann.
- Besonders relevant für dividendenstarke Unternehmen oder solche mit starker Kapitalrendite.
📘 Short Interest
📈 Was ist das?
Short Interest zeigt, wie viele Aktien eines Unternehmens aktuell leerverkauft wurden – also von Investoren geliehen und verkauft, in der Erwartung fallender Kurse.
🧮 Wie wird es berechnet?
Der Wert zeigt den Anteil der Aktien, der aktuell auf fallende Kurse spekuliert wird.
🏛️ Wofür ist es wichtig?
Short Interest dient als Stimmungsindikator: Ein hoher Wert deutet auf Skepsis oder negative Erwartungen gegenüber dem Unternehmen hin – kann aber auch zu einem „Short Squeeze“ führen, wenn der Kurs plötzlich steigt.
🎯 Was bedeutet das für Anleger?
- Ein niedriger Short Interest deutet auf Vertrauen in das Unternehmen hin.
- Ein hoher Wert kann ein Warnsignal sein – oder eine Chance, wenn sich die Stimmung dreht.
- Besonders spannend in volatilen Märkten oder vor wichtigen Quartalszahlen.
📘 Employees
📈 Was ist das?
Die Mitarbeiteranzahl zeigt, wie viele Personen ein Unternehmen weltweit beschäftigt – ein Indikator für Größe, Struktur und Geschäftsmodell.
🧮 Wie wird es berechnet?
🏛️ Wofür ist es wichtig?
Sie hilft bei der Einschätzung von Skaleneffekten, Effizienz und Personalkosten. Zusammen mit Umsatz und Gewinn lassen sich Kennzahlen wie Produktivität je Mitarbeiter ableiten.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Viele Mitarbeiter bedeuten große operative Komplexität – aber auch hohes Umsatzpotenzial.
- Produktivität je Mitarbeiter ist ein wichtiger Indikator für Effizienz.
- Besonders spannend bei stark wachsenden Tech- oder Industrieunternehmen.
📘 Umsatz je Mitarbeiter
📈 Was ist das?
Der Umsatz je Mitarbeiter zeigt, wie viel Erlös ein Unternehmen durchschnittlich pro Beschäftigtem erwirtschaftet – eine Kennzahl für Effizienz und Produktivität.
🧮 Wie wird es berechnet?
Die Mitarbeiterzahl stammt in der Regel aus dem letzten verfügbaren Jahresbericht.
🏛️ Wofür ist es wichtig?
Diese Kennzahl hilft, Geschäftsmodelle zu vergleichen – insbesondere zwischen arbeitsintensiven und technologiegetriebenen Unternehmen. Ein hoher Wert deutet auf Automatisierung, Effizienz oder hohen Wertschöpfungsanteil hin.
🧮 Berechnung
🎯 Was bedeutet das für Anleger?
- Ein hoher Umsatz je Mitarbeiter spricht für ein skalierbares und margenstarkes Geschäftsmodell.
- Ein niedriger Wert kann auf arbeitsintensive Prozesse oder geringere Wertschöpfung hinweisen.
- Besonders hilfreich beim Vergleich von Tech- vs. Industrieunternehmen.
Technoprobe Aktie Analyse
Analystenmeinungen
17 Analysten haben eine Technoprobe Prognose abgegeben:
Analystenmeinungen
17 Analysten haben eine Technoprobe Prognose abgegeben:
Technoprobe Events
🇩🇪 Neu: Alle Transkripte jetzt auch auf Deutsch verfügbar!
Abonniere Premium, um Transkripte und KI-Zusammenfassungen auf Deutsch zu lesen.
Vergangene Events
|
NOV
11
Q3 2026 Earnings Call
vor 7 Tagen
|
|
AUG
5
Q2 2026 Earnings Call
vor 4 Monaten
|
aktien.guide Basis
Technoprobe — Q3 2026 Earnings Call
1. Management Discussion
Good afternoon, everyone, and welcome to Technoprobe's 9 Months 2026 Financial Results Presentation. [Operator Instructions] And now I have the pleasure handing over to Technoprobe's CEO, Stefano Felici. Please go ahead, Stefano.
Good afternoon, everyone, and thank you for joining us for Technoprobe's results presentation for the first 9 months of 2026. As usual, I'm with Stefano Beretta, our CFO, presenting the 9 months of 2026 results and the guidance for the last quarter of this year. We delivered strong growth during the period, supported by AI-related demand and our ability to translate that demand into operating results.
Our performance in the first 9 months of 2026 reflects the combination of structural AI growth and strong company execution. Revenue reached EUR 787.4 million, up 68.8% compared with the same period last year. Gross profit increased by 116% to EUR 447.3 million with a gross margin of 56.8%. EBITDA reached EUR 376.3 million, up 158% with a margin of 47.8%. What stands out is that profitability grew significantly faster than revenue, demonstrating the operating leverage in our business as volumes increased.
On the demand side, growth in GPUs, CPUs and ASICs continues to support our business. At the same time, increasing device complexity requires greater test intensity and more testing sessions. Our opportunity, therefore, reflects both rising volumes and more demanding testing requirements. On the execution side, our focus will continue to capture this demand and delivering at scale while maintaining consistent operational performance.
We are also laying the foundations for further improvement. That means investing in capacity and strengthening the manufacturing processes needed to support a larger business. Being capacity the key driver also for the next year, in addition to a deep dive into 9 months and quarterly financial results, we will discuss the state of art of investments we are making to expand the manufacturing capacity. Let me now hand over to Stefano Beretta for further details on 9 months' results.
Thank you, Stefano. Good afternoon, and thank you for joining us. Today, I will briefly review our third quarter and 9-month results before focusing on the most important message, how we are preparing Technoprobe for an extraordinary phase of capacity growth in 2027 and 2028. The third quarter marked another record for Technoprobe.
Revenue reached EUR 323.3 million, up 130% compared to the same period last year and 16.7% sequentially, reaching the high end of our outlook range. Gross profit was EUR 197.7 million, representing a margin of 61.1%, while the EBITDA reached EUR 170.2 million with a margin of 52.6%.
For the first 9 months, as already showed by Stefano, revenue was EUR 787 million with an increase of 68.8% year-on-year and gross profit reached EUR 447 million with a margin of 56.8% and EBITDA was EUR 376 million, up 158% with a margin of 47.8%. This growth was organic and driven primarily by the artificial intelligence and data center applications. The consumer segment recorded moderate growth, while automotive and industrial continued their gradual recovery.
Foreign exchange remained a headwind compared to the same period of prior year with a negative impact of approximately EUR 30 million on the 9 months revenue with the 9-month average USD-euro rate at EUR 1.16 versus 1.12 for the same period of 2025. Profitability, both at gross margin and EBITDA level, benefited largely from the improvement in production efficiency, product mix, operating leverage as well as the partial expansion of manufacturing capacity realized so far.
Stable overhead and R&D costs also supported the strong EBITDA performance, even including a negative ForEx impact for approximately EUR 22 million, which would have brought the year-to-date margin at 48.6%. Our financial position gives us the ability to keep investing ahead of growth. At the end of September, our positive net financial position stood at almost EUR 800 million, while operating activities generated approximately EUR 241 million of cash during the first 9 months.
These results matter not only for what we have delivered, but also for what they allow us to do next. We can invest in facilities, equipment, people, and systems today rather than wait until demand puts additional and unsustainable pressure on our ability to serve customers. Let me now turn to our capital expenditure plan, which is the central element of our preparation for the next phase.
We confirm approximately EUR 350 million of investments through the first quarter of 2027, with around 75% expected in 2026 and the remaining 25% in the first quarter of next year. The investment plan slide shows EUR 167 million finalized in the first 9 months and additional EUR 158 million already committed at the end of October. So approximately EUR 270 million of the overall program is already allocated to Italy and EUR 80 million to the rest of the world, in particular to Taiwan and China.
The program combines new facilities with the optimization of our existing manufacturing footprint. We are not simply adding floor space. We are increasing throughput, introducing the next-generation laser cutting and assembly equipment, reconfiguring layouts and preparing dedicated production lines. At the Cernusco Lombardone, the completion of the new facility is now expected in December 2026 with a ramp-up targeted for February 2027.
This brings forward the construction completion compared with the timing discussed at the half of the year and adds 4,000 square meters for probe head assembly. Consistently, additional space in the other part of the facilities, especially in Agrate Brianza, will support further expansion in probes manufacturing. In parallel, we are repurposing existing production areas and improving manufacturing processes across our sites.
Together with a new facility, all these investments are expected to bring our annual manufacturing capacity run rate to approximately EUR 1.6 billion in the first quarter of 2027. We are also developing a further investment plan for a total amount between EUR 150 million, EUR 200 million to the end of 2027 and without increasing the footprint. That could progressively increase that capacity run rate to approximately EUR 2 billion by the end of 2027.
Just to avoid any misunderstanding, these figures describe manufacturing capacity, not revenue guidance, and the timing and utilization of that capacity will depend on the demand and the execution. Our ambition extends beyond the next quarter and beyond 2027. So we are preparing the ground for an extraordinary expansion capacity across 2027 and '28 so that Technoprobe can support customers and to substantially greater scale. The priority is operational readiness.
Buildings and equipment must be ready, but so must the people who operate them and the system that coordinates them. That is why the CapEx program cannot be viewed separately from our digital transformation and hiring program through which by the end of this year, we will have more than 5,100 employees with an increase of approximately 1,700 people compared to the beginning of the year.
Our preparation also extends to China, where Nexprobe combines our Shanghai office with the Suzhou facility, covering approximately 12,000 square meters. The platform brings together local probe manufacturing and assembly, supported by our proprietary patents and technology transfer from Italy with local engineering and customer support.
The ramp-up is expected within the first quarter of 2027. Across the group, our manufacturing investment builds on a shared proprietary technology base spanning ceramics, lasers and precision mechanics. So let me turn the floor to Stefano Felici, who can walk you through this page.
Yes. Thank you, Stefano. Let me close with the technology that underpins our growth and positions us for the opportunities ahead. At the heart of Technoprobe is a proprietary technology core, spanning ceramics, laser technology, precision mechanics, PCBs and MLOs, electronics and MEMS. Our strength comes from bringing these capabilities together to solve increasingly demanding test challenges.
As semiconductor technology advances, this shared foundation allows us to deepen our presence in existing markets and expand into new applications. In AI and high-performance computing, customers need greater test capacity and throughput while managing higher current and more demanding thermal conditions. Our capabilities in parallel testing, high current handling and thermal management directly address these needs. As silicon becomes more complex, test intensity per chip also increases.
Fine-pitch MEMS, dense contacts and precision integration enable us to meet tighter contact requirements, reinforcing our technical differentiation. In HBM, the challenge is to combine test parallelity with speed and power handling. Our capabilities extend up to full wafer vertical probe cards, supporting our expansion in this application. Silicon photonics opens another avenue for growth.
Here, our capabilities include autonomous electro-optical probe cards with embedded high accuracy and stable fiber array unit positioning. This brings optical and electrical testing capabilities together to address applications such as co-packaged optics. Across industrial and AI power applications, we can apply our expertise in high current handling, thermal control and stable contact across temperatures to markets, including ADAS, microcontrollers and wide band gap power devices.
The key point is that the same proprietary technology base supports multiple growth opportunities. We can build on existing expertise, combine capabilities in new ways and tailor our solutions to customers' evolving requirements. Our 9-month results demonstrate the financial performance this positioning can support. The investments we have outlined today are designed to give us the manufacturing scale to pursue the opportunities ahead. Let me hand over to Stefano Beretta for the fourth quarter guidance and final remarks.
Thank you. Let me briefly address the near-term outlook. The forecast for Q4 largely reflects the impact of the digital transformation process launched on October 1, 2026, which led to the full adoption of a new ERP, a new MES and new warehouse management systems, together with other integrated vertical systems.
The impact on operation was, as expected, significant during the first month of adoption and a full recovery in efficiency is expected by the end of 2026. For the Q4, so we expect revenue of EUR 270 million, plus/minus 3%, a gross margin of 54.2%, plus/minus 200 basis points and an EBITDA margin of 45.1%, plus/minus 200 basis points.
As set out in our prior press release, we almost confirm our full year 2026 range of revenue with a gross and EBITDA margins in the region of 56% and 47%, respectively, in the mid-range. The temporary operational effects of the systems' transition and the cost of preparing our organization for the next ramp should be viewed alongside our long-term investment priorities.
So overall, we remain highly positive about the opportunity ahead, while recognizing the uncertainties associated with geopolitics, trade policies and the fast pace of recovery across end markets. Our response is to focus on what we can control, technology, capacity, people and execution. Thanks for your attention. We can now move to your questions.
[Operator Instructions] The first question comes from Giovanni Selvetti.
2. Question Answer
Can you hear me well?
Yes.
I have a few. The first one is really on CapEx. If you can elaborate a bit more, maybe, Stefano, you mentioned it before, but just to understand if I got it correctly, this new EUR 150 million to EUR 200 million of additional CapEx, is it going to be mainly, let's just say, machinery or is like the purchase of another factory or the building of another factory?
And in a way, what are the drivers in a way of this additional CapEx, whether it's more demand for GPUs or if you're preparing for the ramp-up in production of HBM, if you can kind of give a sense on that? And maybe if we stay on HBM, whether if you have an update for us to share on the qualification process of the other 2 memory players?
Thank you, Giovanni, for these questions. So that brings me the opportunity to reiterate the message that it was mentioned during my prepared remarks. So the new additional CapEx do not relate to new footprint. So what we expect to invest in the second part of 2027, so starting from second quarter to the end of the year relate only to equipment machineries and systems, and that will allow us to increase the entire efficiency of our production because we will be able to better allocate the equipment altogether for certain department flows.
And to answer to the second part of your questions, there are no dedicated departments by products because our production is, let me say, transparent in terms of final output. So we can manufacture needles for head, board and certification and what else in our production flow. That can be almost easily translated into the final product, depending on the demand that we are facing from customers. So there are no specific department allocated to specific products.
Okay. Maybe one for HBM.
Yes, I think you were asking about the qualification status. So we -- I think we can confirm that we have been qualified by one of the players and still in qualification for the other 2. And we can say that for next year -- first of all, for this year, we expect a revenue of around EUR 10 million. And for next year, a multiple of that number that will be at least by 3.
Okay. That's very clear. But with -- if it's possible, you are assuming the same, let's say, x3 with the same customer or x3, including also like assuming the qualification of the others?
With the same customer because we cannot, let's say, make any prediction until the qualification is done with the other 2. So the revenue is projected with the same customer right now.
The next question comes from Alexander Duval.
Alex from Goldman Sachs. Obviously, you've issued a new guidance of this EUR 2 billion capacity run rate by the end of '27. Consensus on a full year '27 basis is more like EUR 1.65 billion. So just wanted to understand what the run rate would mean in terms of that full year sales. How should we think about those overall revenues in '27 that can be implied by that new run rate as you ramp, assuming the demand is there?
And then secondly, for 2026, you did raise your revenue materially, but it seems like margins haven't increased to the extent one might have expected. So just wanted to understand that. Does it reflect conservatism? Or is this perhaps a preparation for the expansion ahead? And I've got a quick follow-up.
Okay. About the capacity run rate. So again, let me reiterate clearly the message. This is what we are preparing to be able to manufacture by the end of 2027. So at the end of Q1, we expect to be able to deliver EUR 1.6 billion on a yearly basis, starting from end of Q1. So consensus reflects revenues rather than capacity.
So if you project at the year-end, the ramp between EUR 1.6 billion and EUR 2 billion will be gradual based on the investment growth together with the demand from customers and the utilization we will be able to put into our fab. So this is the projection of a potential ramp that will be available only at the year-end. So it doesn't mean at all we will be able to deliver EUR 2 billion right now by the end of 2027.
Understood. And perhaps on the margins?
For the margin, we expect the operating leverage will be more and more significant as far as we go to -- from, let's say, EUR 1 billion for 2026 to EUR 1.6 billion run rate to EUR 2 billion run rate. The EBITDA margin, considering especially the SG&A and the R&D impact on our accounts that are limited compared to the revenue growth, will be reflected in a growth of the EBITDA margin as well. Still to be quantified because we need to see the ramp.
And by the way, if you look at the 2026 last quarter's profitability, you will see a slightly decrease in the profitability. Most of that is related to volume, but there is also a component related to additional costs we are facing in the Q4, especially related to labor. This is a message we want to deliver very clearly because we have a hiring program for 2026 that consider approximately 1,700 hires. So an exceptional effort entirely designed to support the rapid ramp-up we expect in 2027.
A good portion of these hires do not produce revenue right now, but we are recruiting well ahead of the ramp because skilled manufacturing capacity cannot be created overnight. So the new colleagues need time to train, learn our processes and become fully productive. We would rather have people in place and trained before we need them than arrive late.
So with the equipment installed, but insufficient trained staff to operate it effectively. So this choice comes with some temporary inefficiency. We will incur cost before the full contribution of those hires is reflected in output. So our financial strength likely allows us to absorb that near-term impact, and we regard it as a deliberate investment in readiness and not a reason to delay the preparation of our customer we require.
Super clear. And if I could just squeeze in one very quick follow-up. Obviously, you reiterated the EUR 10 million on HBM memory revenues, and you've now talked about tripling that. Obviously, there's been some discussion in the industry about pushouts of stack heights of HBM. So I just wondered on a multiyear basis to what degree that impacts how you're thinking about the potential on HBM if we look out several years, if at all?
The potential for HBM is really related to our core technology, which is a vertical technology. So we are leveraging it from technology developed for logic, logic devices like GPU, CPUs, which are typically much more complex. And the full potential, we expect to see the full potential of our technology with the next generation of HBM. So I'm talking about HBM5. But right now, we see already there is a lot of interest to qualify this new technology, the technology we are proposing to be ready for the next generation. So I think we will see the full potential in a couple of years from now.
The next question comes from Alberto Gegra.
Hope you can hear me. So my first question is on capacity. You're giving this indication of capacity for 2027 to EUR 2 billion run rate, but you stated that you are expecting to further increase in 2028. So just to have a sense, a rough idea of the CapEx that we should expect in 2028. The second on the guidance, the step down in the last quarter seems a bit more pronounced than the initial expectation. So I understand some internal inefficiency. Just wondering if there is anything to flag on the demand side.
And the last one is a general question about visibility because in August, you talked about good visibility from your customer, I mean, not in terms of order, but on project volume expectation and so on. So how this visibility has changed today? I mean, are you incrementally more or less confident about the growth of the next 2, 3 years? Are you seeing stronger commitment from customers compared to the past?
Thank you, Alberto. So let me take the first point about 2028 CapEx. It's a bit earlier today, again, to understand which will be the further of the further CapEx plan. So we are now completing a very important run of investment to be completed in the next couple of months.
And then we just mentioned another round of investment through the entire 2027, almost fully allocated to equipment and machineries and clean rooms and what is -- what will enable us to increase internal efficiency without increasing the footprint. So for 2028, of course, there will be other options to be explored. But so far, they are still on the paper. And it's very, very early stage to show that. And about the other point, we don't see any decrease on the demand from customers right now.
So the Q4 decline is almost entirely, if not entirely allocated to the inefficiency for the new ERP ramp-up, so same logic, as we mentioned for the hiring program, the same logic applies to this digital transformation. So the new ERP went live on October 1, and this is marking a fundamental step in building the infrastructure required for a larger and more complex techno probe.
So the operational slowdown has been as we initially expected at the quarter, the complete and necessary cutover, for example, required 4 days of total shutdown. October then involved the amount of operating inefficiency as the team adapted to the new environment and full operational recovery is expected by the end of November, beginning of December.
So we should be clear that a successful cutover doesn't mean that every process is immediately at full efficiency. The priority now is to complete the stabilization and to ensure that to all our customers, translating that into new infrastructure for a day-to-day execution. And the broader program includes a full adoption of the ERP, the MES, the warehouse systems.
This is intended to give us a stronger visibility and control across planning, across production and inventory and help us to use our growing resources more efficiently. This is why we would encourage you to look at the transition in the context of the next couple of years rather than focusing on the last quarter, Q4 2026. So we are putting in place people and infrastructure required for a completely new chapter of Technoprobe in the service of all our customers.
For the visibility, we still have a very -- we're not seeing any slowing down, especially in the AI visibility. So all the main players are still demanding us to increase capacity, and they want this capacity as soon as possible. So at this moment, we don't see anyone slowing down.
The next question comes from Bernd Klanten. Can you hear us?
Yes. Sorry, can you hear me now?
Yes. We can.
Sorry about that. Another follow-up on capacity, if I may. I appreciate that it's too early to talk about CapEx in 2028, but you've also shown that you can expand capacity quite a bit without spending new CapEx. So without any CapEx assumption, how do you think about that EUR 2 billion number evolving over 2028? And then I just wanted to qualify on capacity as well, whether that excludes the opportunity from Nexprobe? And then I have a follow-up, if I may.
So let me say again, 2028, we will have still 2027 to be started. And we are totally focused right now to deliver what we have planned already and secured with our customers. For 2028, of course, there are already some discussions in place, but that will be necessarily rediscussed with the main customers we currently serve to understand also the speed of that growth.
For Technoprobe, it's pretty, let me say, easy to plan future growth as far as we have cash enough, so again, to be self-funded is really a very clear base and important base for Technoprobe to have cash enough to fund our own investments and also to be prepared with a strong supply chain, we are currently securing that will grant Technoprobe to have equipment enough in case we would need. So a further development will be decided and disclosed in the next press releases. So for now, we remain stick to 2027.
Got it.
Yes, to the point of Nexprobe. Yes, Nexprobe is included in this plan for 2027. So the ramp will start in January. And we expect in terms of volumes and turnover that they will be able to reach more or less [ $ ] 100 million revenue in the next 3 years. So by the end -- by 2029, we expect the volume will reach a $100 million contribution only Chinese market -- only for the Chinese market.
And then one other question on custom ASICs in particular. Can you remind us of the status quo on the adoption of vertical MEMS there for custom ASICs and where you stand with the key players?
So no, at this moment, we are one of the main suppliers for the ASICs -- all the ASICs customers. So we introduced new technologies, high-speed and RF technologies for these -- also for these devices. And we are a point of reference for ASIC testing.
The next question comes from Martin Jungfleisch.
I also have a couple, please. Maybe if I can start on the CPU side. Can you disclose what the CPU testing growth versus the GPU and how you would that expect to develop into 2027? That's the first question, and then I have another one.
Sorry, Martin, can you repeat the beginning of your question because the line went busy for a couple of seconds. About CPUs.
I'm in Munich at the SEMICON. I was just wondering about the -- if you could disclose the CPU-related growth compared to GPU-related growth and what you would expect how that growth would kind of trend into 2027, so the CPU versus GPU testing?
Actually, we -- for 2027, we don't see so much difference compared to 2026 as far as the ratio between GPUs and CPUs. So we expect some very large campaign of GPUs, new GPUs and as well followed by CPUs. So we will -- let's say, the biggest portion will be still on the GPU side, but -- and the CPU will just follow.
Okay. No, that makes sense. And then just 2 clarification questions, if I may. The first one is on the HBM side of things. When you expect this EUR 10 million this year and the EUR 30 million -- around EUR 30 million next year, that is just for the base die testing. Is that correct?
No, not only for the base die.
Okay. So it's also the DRAMs. And then just finally, just also a bit more clarification on this Q4 sales guidance. Is it fair to assume that the impact on the Q4 would be roughly EUR 50 million on the top line roundabout?
Yes, on the top line. Yes, correct.
The next question comes from Harry Blaiklock.
The first is just on a clarification on the comments on custom ASICs. You mentioned that you're one of the main suppliers for custom ASICs. But I thought last quarter, you were saying that you were kind of just in the process of qualifying and gaining some momentum in custom ASICs. So what's changed there? And when you say main customer, is that for designs that are going into production next year? Or are you already getting meaningful revenues coming through for custom ASICs?
No, no. We have already good revenue on the custom ASICs. So after qualification, we got very quick ramps on several new devices. So that's why when I'm saying that we are a point of reference is already actual. It's not for the future. Of course, there are many new NPIs coming in the next months. But we are already -- we have already a very good technology for these types of devices already in production.
Okay. All right. And then on the capacity point, I mean, you've -- the guide for this year is super helpful for the EUR 2 billion. Like over the past year or so, as you've been adding capacity, you've shown that you can execute on this stuff relatively quickly and find more capacity when needed. Do you see any upside to that EUR 2 billion number? Or is that very much kind of capped by the kind of the existing space that you have?
Well, with existing spaces, I think we are comfortable for EUR 2 billion capacity. So especially if you will be able to deliver all the growth, the equipment and to receive from the supply chain, all the equipment we need. So we don't have a particular constraint on space. What we have seen as a constraint was the hiring, and this is why we are trying to hire well in advance all the people that we need to run the fab in the next 12 months. So this is the first point.
The second constraint, again, is on a supply chain base. So we ordered already -- we committed already a large part of that investment for 2027 to our suppliers in order to secure their capacity to serve Technoprobe. And most of the suppliers are, let me say, totally exposed to Technoprobe for their products and machineries.
So this is very important for us. These are the only points we see as a constraint. Again, we don't have any constraints in terms of cash and in terms of decision. As you can see, when we invest EUR 200 million more, we can generate EUR 400 million more revenue. So even from a financial perspective, I'm pretty comfortable as a CFO to approve an investment like that.
Yes. Makes a lot of sense. And then one last question just on the competitive dynamic that you're seeing. I know historically, you've kind of had one main competitor in the leading-edge logic space. But one of your Taiwanese competitors who historically has had strong custom ASIC business has been quite vocal about their ability to win share in the vertical MEMS space as they're adding capacity. I was wondering if that's something that you're seeing at all or whether you still very much see this as kind of a duopoly at the leading edge between you and your U.S. peer.
Okay. So what -- first of all, I would like to say that we respect all the competitors. So we watch them what they're doing, and we very carefully check in the market the situation. But on my perspective, I can tell you that we think we are -- I mean, the numbers are telling that we are the #1 player for the logic in the logic space.
So probably the player that should worry is the #2 because the #3, of course, we will try to get some shares, but the situation will be worse for the #2 supplier rather than #1. On our side, we think we still have the best technology, and we are already preparing for the next generations of chips.
The next question comes from Craig Mcdowell.
I had a question on capacity. Just when you put out these numbers, EUR 1.6 billion by the end of Q1, EUR 2 billion by the end of Q4 '27, can you maybe help us understand what assumptions are in there in terms of price and mix? Presumably, volumes fixed, but there must be a price and mix assumption in there.
If you could give some color on that. And linked to that, on pricing more specifically, I think we're hearing comments that maybe on memory testing, there's been some pricing up on a like-for-like basis in memory wafer test. Just maybe comment whether you're participating? Or is that something that you're able to do?
Thank you, Craig. So the capacity projection has been calculated with a constant price mix impact. So we do not project any particular increase in pricing or in the mix of the products. Of course, there will be some changes as far as the technology will go further. There will be more complex product, probably with a higher price, but just because the components are more expensive.
But in terms of negotiation with customers, as usual, we do not expect that price increase will come directly from Technoprobe even in a situation of extra demand compared to the offer. So the current projection of capacity is, again, calculated with a comparable and constant price mix.
Very clear. And just on gross margins as well, maybe if you could just clarify if there's any -- in the Q4 guide, if there's any one-off related to the ERP implementation that we should be aware of just as we think about gross margin trajectory into '27 as well? That would be great.
Thank you again. So in terms of gross margin, there will be no particular one-off cost for the ERP introduction and all the digital transformation. The vast majority of the costs will be -- are capitalized and amortized through the utilization of the software. So they are not impacting directly the P&L as a one-off cost. So the most impactful cost for Q4 with no particular revenue allocated related, as I mentioned before, to labor, especially.
So the entire hiring with data analyzation, we have concluded in Q3 and Q4, will be impacting the Q4 P&L, but again, without associating particular revenues. So this is the main explanation of the Q4 little squeeze of the profitability, that is temporary. It's not a one-off because the labor cost will be projected also over the other quarters and go on. But in particular, for Q4, there will be some, let me say, not recurring -- not correlated cost to revenue.
The next question comes from Fabio Pavan.
Actually, most of them have been asked already. So maybe to sum up, I would love to ask you if you can share with us your expectation in terms of revenue line evolution for '27, considering what you just shared with us. And also, Stefano, you were mentioning we should look to mid long-term prospects. So with that in mind, I was wondering if you are considering to share with the market an updated target model maybe at some point in '27.
So let me take the first point. So revenue in 2027, we go back to the visibility. Visibility is still short by quarter, even if we have more conversation with customers when they want to be, let me say, more allocated with a longer-term view for 2027, but still, let me say, to quantify on a right number, '27 revenue expectation is still very early. What we want to focus again is the capacity.
The revenue is a consequence. If you don't have capacity, you don't have revenue. So our first point in -- our first focus in our mind is to secure the capacity. Revenue will become more clear in the next few quarters. About the target model, again, is very consistent with the capacity run rate. So the target model in the short term in less than -- a little more than 12 months is to arrive at EUR 2 billion.
But if you think that only 1 year ago, 2025, we were still at less than EUR 700 million. It means like 3x in less than 2 years. So it's a big jump. And for the moment, this is as much as we can do. Then for 2028, again, we are still discussing new plans, but that will come with new customer conversation and to see also the market -- how the market evolves.
The next question comes from Oliver Wong. I think you're having some technical problem. We will then just move on to the next question. The next question comes from George Brown.
This is George Brown from Deutsche Bank. I have 3, if I may. I'll take them one by one. Just firstly, I understand that you flagged this temporary impact in Q4 from this digital transformation project, the ERP system, et cetera. I think you said the top line impact was roughly EUR 50 million. Just wondering what would be the underlying margin in Q4 without this sort of top line volume impact? Would the Q4 margin be similar to Q3, excluding this temporary impact? Or would it be maybe slightly lower due to the labor cost? And I have a second and a third.
Yes, that will be -- would have been slightly lower than Q3 profitability because of what I mentioned before. So the new hiring, additional hiring completed at the end of Q3 and largely impacting also Q4, together with new depreciation and amortization. So in terms of a normal run rate, we would have, let me say, similar revenue with similar capacity, but a little lower profitability.
Okay. Perfect. And then secondly, just on capacity. I know you've had a lot of questions, but I'm wondering what's the incremental capacity that the new facility in Milan brings, which is ramping in Q1 of next year. How much incremental sales capacity does that bring when it's fully ramped? And how many quarters does it take to ramp up to a full run rate?
So the ramp rate will be pretty quick because the new facility will include a complete assembly department. So -- and that will be very, very efficient from a logistic point of view, internal logistic point of view. So we will expect the increase of the ramp in the first quarter, let me say, to arrive at a rate of EUR 130 million revenue per month in the Q1.
So this is the run rate that we expect to reach very, very soon. And if you consider that, again, 1 year ago, we were at EUR 700 million per year, a little less. So it means twice the capacity we had 12 months ago. So this is exactly the multiple we have been able to reach combining internal efficiency and new footprint.
Okay. And maybe just to double click on that. So I mean if I sort of annualize the Q3 run rate, you're sort of nearly at EUR 1.3 billion roughly. And I think -- just correct me if I'm wrong, you're saying that the new facility would just bring you basically to EUR 1.4 billion, so sort of an incremental sales of EUR 100 million. Does that -- I mean, that feels a little bit low given that it's a fairly large facility that you've invested quite a significant amount of money in. But yes, just maybe a clarification on that point.
Sorry, maybe I didn't follow exactly your calculation earlier, and I didn't write on my paper, so I couldn't follow exactly what you mentioned.
No. I was just wondering exactly sort of how much incremental capacity that Milan facility brings, but I guess you answered it. So I can go on to my third question, which is on the new products, I know you talked about ASICs and HBM, I'm just wondering on silicon photonics as well. Is there any sort of updates on customer engagement qualifications or anything else that could be interesting on the silicon photonics side with Eclipse?
Yes. Thank you for asking. Yes, silicon photonics, we are right now in qualification with 3 major players. And we think we have a solution that is ready for HVM, so for high volume rather than for a lab, okay? And we expect to complete the qualification by mid of 2027 and then start with some production. So right now, we can't give you an estimate for the revenue because it's still early. But as soon as we're going to be close to complete the qualification or already completed, we can give you an update for this.
The next question comes from Oliver Wong.
It's Oliver Wong from Bank of America. My first question is on revenues, specifically demand into next year. I think earlier this year, it was quite clear that you guys were capacity constrained. I understand that with the low visibility, it's unclear if that will continue to be the dynamics for next year.
So I was just wondering for demand, I was wondering where sort of the uncertainty or sort of the variability stems from? Is it -- I understand a lot of your revenues pertain to GPUs. Is this -- is the uncertainty kind of stemming from sort of not being sure about GPU volumes for next year or perhaps customer inventories or perhaps something else? It would be helpful to get more color there.
What we expect for 2027 is that GPUs and all the data center application will be largely impacting our P&L and our allocation. So currently, we exceeded largely more than 50% of our current production fully engaged in data center and within the data center, especially allocated to AI applications. So we do expect for 2027 to reiterate this message.
So we don't see any decline in that trend. We have conversations with customers. And we have conversation also with new customers for new applications that we truly believe will become with large volumes in 2027 for what we didn't have in 2026 because of capacity constraints or other market share taken by our competitors. So -- but to answer to your question, the answer is yes. So GPUs and ASICs and everything related to AI will be still the most important portion of our revenue.
Got it. My other question is it fair to say that the ERP implementation, the sort of amortization costs on your margins will continue throughout 2027? Any color there?
Yes, but the impact of this depreciation will be almost negligible, because if you split them through, let me say, 10 years, the total cost of the system implementation would be not that relevant, impacting in the long-term figures, especially when you ramp revenues in that speed. So we are not completely worried about that. And by the way, just to conclude, the depreciation of the prior ERP will be terminated. We will have, from next year, a saving from that side.
The next question is from Alberto Gegra.
Just a few follow-ups. The first is on the number 2 supplier. So your competitor sounds more and more vocal on the possibility of gaining market share in 2027 in the GPU. So which kind of assumption are you making on the potential evolution of the market share? Then maybe a word on the consumer market, as we are seeing several outlook quite negative on 2027. Maybe if you can share your view. Lastly, on the industrial partner, so you have this new shareholder that increased the stake. Maybe some comments on the strategic rationale behind it, their specific project. Anything will be helpful.
Okay. About GPUs, I think it was for us expected to have some competitors, of course. I mean, healthy market needs at least two suppliers. It is not a surprise, but I think -- we think, first of all, that the market will be big enough also for two suppliers, and we think to have the right technologies ready to address the next challenges for the GPUs. So I would say that we are not worried about market share for GPUs. So as far as consumer, it is still early to see what is going to happen in 2027. We see a slight recovery in Q4 -- for the Q4 consumer market, but still early to speak about 2027 for consumer.
Yeah, about the industrial partnership with Vector Line, of course, this is a confirmation of the strategy of the group to take advantage of industrial partnerships like we did in the past, in the recent past with Teradyne and with Advantest, so the strategy with Vector Line remain the same. So having more clear visibility on the ecosystem of the same space.
So we are all involved in this, let me say, small market with very few players and connecting each others with concrete investments rather than commercial agreements, simple commercial agreement will speed up the technological progress and customer relationships. So this is what Vector Line will bring to us since the beginning. So additional commercial relationships and additional knowledge about the market or what we were missing until this partnership.
As there are no further questions queued, I will now hand back to the speakers for any final comments before bringing this presentation to a close. Please go ahead.
Thank you, everyone, for joining us today, and please stay tuned for the end of the year results. Thank you.
This presentation will now come to a close. Thank you.
Transkripte auf Deutsch freischalten
- Alle Event Transkripte auf Deutsch
- Sofortige Übersetzung
- KI-Zusammenfassungen für die wichtigsten Insights
Technoprobe — Q2 2026 Earnings Call
1. Management Discussion
Good afternoon, everyone, and welcome to Technoprobe H1 2026 Financial Results Presentation. [Operator Instructions]
I now have pleasure handing over to Technoprobe CEO, Stefano Felici. Please go ahead, Stefano, the floor to you.
Good evening, and thank you for joining us. I'm with Stefano Beretta, our CFO, presenting the first half 2026 results and the guidance for the third quarter of this year. As usual, a Q&A session will follow at the end of the presentation.
Let me start by saying that the first half 2026 represents another milestone for Technoprobe. Our performance demonstrates not only outstanding financial execution, but also strength of our positioning in what we believe is one of the most attractive structural growth markets in the semiconductor industry. We delivered record revenues of EUR 464.1 million, growing 42.4% year-over-year and 48.2% sequentially as a result of a by broad-based demand across our key customers and applications, confirming that the long-term AI investment cycle continues to accelerate.
As volumes increase, we captured significant operating leverage across the business. Gross profit grew almost 66% year-over-year with gross margin expanding to 53.8%, while EBITDA increased nearly 94% to more than EUR 206 million, delivering an outstanding margin of 44.4%. And these results demonstrate the scalability of our business model and our ability to convert strong market demand into superior profitability.
Looking at the key drivers behind these results, execution was clearly been one of the -- of our greatest strength. We achieved record revenues because of the manufacturing capacity improving and at the same time, leveraging our cost structure, allowing profitability to grow significantly faster than revenues.
The combination of execution excellence, operating leverage and margin expansion is exactly what we aim to deliver as our business continues to scale. From a market perspective, AI data center remains by far the most important growth engine for Technoprobe. We continue to see exceptional investment across the AI ecosystem with customer increasing spending to support an ever more powerful computing platforms. We believe this is not a short-term phenomenon, but a structural transformation of the semiconductor industry.
Within this environment, several trends continue to work strongly in our favor. First, data center applications remain the primary driver of demand for our advanced technologies. Second, the rapid evolution towards increasingly sophisticated AI models including the emergence of our agentic AI is pushing semiconductor complexity to new levels. Finally, every new generation of advanced devices require significantly higher test intensity, increasing the value of our solutions and creating additional content opportunities for Technoprobe. These structural trends reinforce our confidence in the long-term growth trajectory of our business.
Looking ahead, we remain very optimistic about the second half demand trends we experienced during H1 are continuing. Customer engagement remains extremely strong. To support this sustained demand, we are continuing to expand our manufacturing capacity, ensuring that we can meet customers' requirements, while preserving the operational excellence and profitability that have characterized our performance so far. Overall, we believe these results demonstrate that Technoprobe is executing exceptionally well, benefiting from powerful secular growth drivers and further strengthening its competitive position.
Next, so let me now provide some context on the market environment and our expectation for the second half of the year. Overall, the picture remains constructive with the trends and momentum observed in the first half expected to continue into H2. However, the pace of growth remains clearly differentiated across the market.
Starting from AI, demand remains exceptionally strong and continues to be the main structural growth engine for the semiconductor industry. Recent industry commentary confirms sustained investment in the AI infrastructure, continued strong demand for leading edge technologies and increasing requirements for high-performance computing, advanced memory and packaging.
For Technoprobe, this environment is particularly supportive. The development of increasingly powerful accelerators, custom processors, HBM solutions and complex chiplet architectures is increasing both device complexity and test intensity. Each new technology generation requires more sophisticated testing, tighter performance requirements and greater reliability, reinforcing the strategic importance of advanced probe card solutions.
We, therefore, expect strong AI growth to continue throughout the second half with no material change in the underlying momentum, visibility remains solid. Customer engagement is high and the broader AI ecosystem continues to invest aggressively in next-generation computing capacity.
Moving to the consumer market. The trend is more moderated. We are seeing slight growth supported by a gradual normalization in smartphones and personal computers, selected product refresh cycles and the progressive introduction of AI-enabled devices. Nevertheless, we are not assuming a broad-based consumer boom. The recovery remains measured and differs by customer, application and product category.
Our expectation for H2 is, therefore, for continued slight growth, broadly in line with the first half. The market appears healthier and more stable than in previous periods. But the magnitude of the opportunity remains significantly below what we are currently seeing in AI and data center applications.
Finally, in Automotive and Industrial, the key message is recovery. Inventory correction and customer destocking have progressed. Order patterns are gradually improving and an increasing number of applications are beginning to contribute to the up cycle. Within automotive, semiconductor content continues to increase as vehicles become more digital, connected and software defined. However, the near-term recovery is still progressive rather than uniformed and visibility can vary across geographies and customers.
As a result, our H2 assumption for automotive and industrial is continued recovery rather than a sharp acceleration. We believe that the direction of travel is positive, but we remain disciplined and do not yet assume a full return to normalized demand across every application.
To summarize, we expect the second half to reflect the same market structure seen in H1. Strong and sustained growth in AI, moderate growth in consumer and gradual recovery in automotive and industrial. This mix is favorable for Technoprobe given our strong exposure to the most advanced and test intensive semiconductor applications and support our confidence in the continuation of the positive trends into the second half of the year.
Now let me turn to Stefano Beretta, who will give you more colors on our figures.
Good afternoon, everyone. As you may have read in our press release, revenues recorded in the second quarter, marked another all-time record for Technoprobe exceeding EUR 277 million, above the high end of the outlook range, registering an increase of 64.3% compared to the same period of prior year, with a sequential increase of more than 48% compared to Q1 2026.
Gross profit is practically doubled compared to the same period of 2025, up to EUR 158.5 million, representing a 57.2% margin, also exceeding the high end of our outlook range. Even more extraordinary is the increase in the EBITDA, which is -- which in just one quarter, reached EUR 137 million, with an increase of 135% compared to the same period of last year, representing an impressive margin of over 49%, well above the upper end guidance during our prior call.
Moving to the year-to-date figures already showed by Stefano Felici. Total revenues were just above EUR 464 million with a year-on-year increase of 42.4%. The gross profit was EUR 249.6 million, 65.7% higher compared to the same period of '25 and representing a margin of 53.8%. The EBITDA closed at EUR 206.2 million, almost double compared to the same period of '25, representing a margin of 44.4%.
On this page, you can see a summary comparison between the financials at the end of the first 6 months, 2025 and 2026. Just to comment that further revenue year-on-year increase was entirely driven by an organic growth of almost EUR 170 million, largely sustained by artificial intelligence volumes as well as a soft recovery in consumer segment, together with a slight recovery in automotive and industrial.
The mentioned growth has been partially offset by the FX headwind for approximately EUR 30 million. In fact, the revenue expressed at constant currency, constant currency used in H1 2025 would have been approximately EUR 30 million higher than reported revenue, meaning an unfavorable impact of more than 6%.
On a gross profit level, the increase in the margin of 760 basis points from 46.2% to 53.8%. As already mentioned in our prior press releases confirm once again, the ability to rapidly increase the production capacity and implement internal efficiency in our production processes, together with the operating leverage across the entire P&L. All of these impacts have been partially offset by the increase in depreciation following the investments in fixed assets made during the latest months to expand our capacity and increase the automation.
Gross profit at constant currency would have been approximately EUR 24 million higher by using the half 1 '25 average rate, bringing the margin well above 55%. At the EBITDA level, the effect of the operating leverage is even more evident, also favored by spending discipline in SG&A and the integration of the R&D departments of the various divisions. Showing an increase in the margin, even including a negative ForEx impact for approximately EUR 23 million, which would have brought the margin above 46%.
Finally, the net financial position has remained almost stable over the last 6 months, during which the cash generated by the operating activities for approximately EUR 93 million was practically all used to fund the capacity expansion made in the same period.
Again, as already anticipated in the previous press release, the group has recently embarked on a path to double its production capacity from 2025 benchmark by the first quarter of 2027 through an ambitious investment in hiring plan. To date, the results exceeded our expectation and we now expect to be able to increase the capacity up to 140% compared to the run rate at the end of 2025. Of course, the complete success will depend on many factors, especially on the ability to quickly adapt to changes in global dynamics and maintaining focus on our technology, on our people and on our ethical governance.
The increase in the production capacity combined with the stronger-than-expected volume growth driven by the artificial intelligence leads us to expect the third quarter with another strong sequential growth in both revenue and profitability and supported by a meaningful operating leverage effect. So as I show in the chart, our investment mix is also evolving significantly. Compared to prior estimate, we have further accelerated the total investment to be deployed by the end of Q1 '27 to approximately EUR 350 million, of which approximately 80% of total investments are now concentrated in Italy where the construction of the new greenfield manufacturing facility in Cernusco Lombardone has already begun and plan to be concluded by the end of Q1 2027.
That said, third quarter of the year is expected to show another sequential record revenue together with robust growth in gross margin and EBITDA margin. So revenues to be about EUR 314 million, plus/minus 3%. Gross margin in the range of 61.5% plus/minus 200 basis points and the EBITDA margin in the range of 52% plus/minus 200 basis points.
And considering that we are more than halfway through the year and based on the volume and capacity information available to us today, we believe it's appropriate to update the revenue and the EBITDA margin targets for 2026, revise it again upwards as follows. So consolidated revenues in the range between EUR 1,050 million and EUR 1,100 million. The EBITDA margin between 46% and 48%, and this is all I have for the comment. So thanks, everyone, for your attention.
Now we can move to the Q&A session.
[Operator Instructions] The first question today comes from Alberto Gegra.
2. Question Answer
Congratulation for this another strong set of results. So I have one question on the implied second half. If you can -- if you have anything to flag just to better understand the reason behind the phasing between the third and the fourth quarter, since you are having a very strong third quarter than the last one slightly down sequentially.
The second question on the capacity increase, just to reconciliate the previous messages on -- of around EUR 1.4 billion run rate of manageable sales by the end of first quarter. So an update on this figure considered the updated CapEx also considering DIS and potential Chinese revenue.
And the third one, if you can update us on the new markets, what are you seeing in the discussion with your potential customers what drivers do we expect in 2027, in particular, between CPU, ASIC, HBM and silicon photonics.
Thank you, Alberto. So let me start for the H2 trend. So for the moment, we guided Q3, of course. Q4 is still under examination. So what we show now is a trend -- an upgraded trend for the year-end, but we still have some lag of information. As you know, the visibility is very short and not yet completed for the Q4.
What we can see right now is that a significant mass production and cyclical trend, especially for the GPUs that led the significant growth in the first half of the year would take a kind of pause for the second part, especially for the last part of the year and then to restart in terms of volumes in 2027. So in the second part, especially in the last part of the year, we expect a bit of slowdown in the GPUs soft replaced by CPUs and ASICs, but volumes will be different in that case. So this is something we expected usually in the Q3 as a kind of cyclicality in the past years. Now the cyclicality has been moved a bit further along the year. So we expect that in Q4.
About the capacity increase, as I mentioned before, we have increased the investment expected by the end of Q1 '27 from EUR 250 million to EUR 350 million, so EUR 100 million more and this additional increase that is almost entirely addressed in the equipment and automation, not only in Italy, but also in all our facility, especially in Taiwan, in Korea and China as well, will allow us to increase again our capacity from what we mentioned in the prior press release that was EUR 1.4 billion at a run rate, at least to EUR 1.6 billion run rate at the end of Q1, meaning [ $1.9 million ] in terms of run rate. This is the most important upgrade we want to show and we want to disclose.
Lastly for the new market, I leave the floor to Stefano Felici.
Yes. So we -- as far as market segment for next year, we don't expect major changes in the ratio between GPU, CPU, HBM. There might be a slight correction in the CPUs, maybe a little bit more CPU demand related to AI, but this is still early to say, but we don't expect a major difference compared to 2026.
So for an emerging market that maybe I can comment is you mentioned silicon photonics. This is can be really considered a new segment. And the situation here is that right now, I mean, there are solution in the market that are more lab oriented. So it's because the customers are approaching this type of test for the first time and it's still a little bit unclear what will be the final strategy how to test these type of devices in volumes. So this year, I would say that still characterization phase, okay?
And there are solutions there that are not for HBM and not for volumes. There are solution for -- more for characterization. What we are preparing for is solution that can address high volume, okay? And we have already developed the core technology for this type of testing and will be up to the final customer to decide when to switch from a characterization phase to a mass production, I mean to test in high volume -- testing high volume for these devices. Probably this will happen during 2027, start of the volumes, but it's still early to predict exactly how much will be the business. So for sure, we will update you in the next call.
We now have a question from Oliver Wong.
A question about HBM. So you mentioned that the next year, you don't expect a significant change in competition with different chips. So have there been sort of a delay in HBM revenues of any sort?
No, there are no different comments compared to prior press releases. So we expect -- we still expect for 2026 to have a very small portion of revenues in the range of EUR 10 million, more or less no more than that by the end of the year. So again, we have been qualified by 1 of the 3 customers and the situation is pretty stable. So we are still in the qualification phase for the other 2 main players of the segment. We do not expect to have additional information by year-end. So we remain stable and consistent.
Sorry, I meant for next year for 2027, since you said you expect a big change in the composition of types of chips, I guess that means HBM will continue to be a pretty small part of the revenue. So I was wondering if there's any sort of delay compared to what you previously may have expected.
Got it. Thank you. So for 2027 in terms of magnitude is still to be defined. So as you know, the definition and the adoption of the technology is still to become what is more suitable for the production of Technoprobe that use a vertical MEMS product rather than cantilever product. So the adoption of this technology is what drives the volumes and the potential campaigning assigned to Technoprobe.
So for 2027, we don't have a particular visibility on that. It doesn't depend on us. What it counts very much for us is to have a technology ready for the moment when it will be necessary. And we are very committed on that, and we know that our product will be successful for the customer. One of them is already adopting in terms of, let me say, prototype -- prototypization it works. So we are very confident it will be successful also in 2027. But again, it's still too early to define which will be the volume for next year.
Yes. And I want to add on this Stefano mentioned about our approach, which is [indiscernible] approach. And this is -- we are leveraging basically our technologies used for Logic. And this is important to say because the vertical, we think that also the HBM will evolve and can be customized for it with -- to perform better in the future.
And -- so this will the better technology will give more flexibility visit to the HBM designer -- design. The other very important things for us is that we want to base I mean this technology on our best core technology that can also produce the same level of profitability that we have also with Logic. And this is typically also in the past the memory market was not the best one as far as profitability. But again, because of a different architecture.
So our main point is to address this market with a better performance, with a different technology that can produce the same results of the technology used for our Logic. And said by Stefano, it doesn't depend on us when the adoption will happen. So we're already going in the right direction. So there is -- we see interest in this technology, but it is still early to say when exactly it will be adopted in mass production.
So the next question comes from Alexander Duval.
Congratulations on the strong results. I had a couple of questions. Firstly, you have raised your CapEx investment this year. I wondered if you could give us some thoughts on the level of investment you might do beyond 1Q '27. Clearly, there's an uplift you're talking about in your cumulative spend up to that point, but would be very helpful to get a sense given the extremely robust AI market.
And second of all, just to double-click on that question about differentiation within memory. I wondered if you could elaborate a bit more on the extent to which technological differentiation that you offer will allow you to surmount some of the sticky relationships one would think that competitors would have in the memory space.
Thank you, Alexander. Let me take the first point about the investments. Your read is very correct. I mean, EUR 350 million to be spent in 15 months, so starting from January '26 to March '27 is very, very challenging. And we are literally committed to deploy all these investments. Right now, at the end of June 2026, we spent approximately EUR 90 million. So we have EUR 250 million more or less left to be spent in the next 9 months.
Very challenging because most of these investment relates to machineries and equipment, depending on the ability of our suppliers to deliver what we have ordered to them. So it could be the case that if not completed by March, something can be delayed for 1 month or 2 months. But overall, the commitment is to spend this big amount for this capacity increase. And this is exactly to deploy the run rate capacity at EUR 1.6 [ million ]. That is already more than double -- largely more than double compared to 1 year ago.
But overall, do not forget the fact that the expansion plan that was launched in the fourth quarter 2025 is been implemented through 2 parallel work streams, so not only purchase of equipment. So each of the 2 work streams has a different execution time line. So the first one that is the most important for the moment in the short term has been quickly and -- that is quickly delivered great results, so involving greater execution complexity and focused on optimizing the existing manufacturing processes, including redesign production workflow, reducing machine processing time, increasing the number of daily shifts, reconfiguring selected factory layouts and all to accommodate additional automation equipment.
So the resulting capacity today is expected to progress steadily month-by-month through the end of 2026. So we don't -- we will not have a big bang at the end of Q1. And this is what is concretely visible right now in our numbers. So we are growing consistently quarter-by-quarter and month-by-month.
The second work stream is, of course, the new 4,000 square meter manufacturing facility, which is already underway and expected to be completed by the end of Q1 '27. This is -- this project has a longer implementation time line, it carries lower execution risks, but at a greenfield facility can be designed and configured in line with the group's specific operational requirements and the contribution to the productivity and capacity will only materialize once the facility become operational.
Yes. I'll take the second question. I hope not to be too much technical to answer to your question, but feel free to ask again more question if you need.
But to answer -- in the simplest way to answer your question is to check and start that from the beginning what happened and tell you what happened with the Logic devices because if we go back 15, 20 years ago, all the Logic devices were tested most of them were tested with about cantilever probes not [indiscernible] about Logic now, not memory, but then I'll make the point why I'm saying this.
But focusing on the Logic, they were tested with the cantilever probes. Cantilever means probes coming from the site and they cannot cross each other. So basically, with that type of geometry, you can contact just a line of PET's, okay? And typically in the periphery of the devices. This was a very standard for -- there are still some devices with just PET on the periphery of the device. And cantilever probes can, of course, contact this line of PET.
This was a -- Logic became a very big technical constraint for the performance of the chip because the designers needed more PET's to be probe in the area and they needed to maybe to put some power supplies in the middle of the device or ground in the middle of the device to get more better power integrity, signal integrity to get a better performance.
So what happened is that for the Logic chips, the designers to put PET covering the whole area of the chip. That's everywhere. So that was really the reason -- the technical reason why cantilever technologies couldn't at that point -- couldn't be suitable anymore for the application. So because if you have PET everywhere also in the middle of the device everywhere, the only way to contact those PET's is in [indiscernible] and that was really why the [indiscernible] technology basically was the winning technology at that point.
So from cantilever everybody switched to vertical and basically, 99% of the Logic market and any Logic chip is tested vertical technology because of this reason. It's a more flexibility for designers to cover and to put all the PET's wherever they want, okay?
So now coming back to memory. Memory, typically the memory chips, the memory devices were simpler than Logic devices. And until now, the PET, I mean, they could be -- they contact for testing are still in line, like can be 2 lines of PET. I mean very similar to the configuration that I just described for Logic. This allow for as far as geometry for [indiscernible] still allow to reach these PET's using microcantilever probes. So from a side, you can contact a line of PET.
Again, our vision, but it is also supported by customers is that it would be much more beneficial now to have PET everywhere because now we are going in the direction where also the HBM is not anymore a very simple memory chip, but it's a very high performance chip. And everybody want to push over the limit the performance of these devices.
And this can be really the reason why at a certain point, the designer will prefer to change the layout and PET everywhere at that point vertical will be the only solution. So I don't know if -- I hope this can explain the differentiation here with the technologies. I don't know if you have -- this clarify your question.
That's super helpful.
The next question now comes from the phone number ending in 893.
Sorry about some technical difficulties. It's George here from Deutsche Bank. Congrats on the great quarter. I have a few questions.
Just firstly, on the new guide for this year. I think maybe you touched on this earlier, but just to double click, if I take your implied Q4 guide, even at the top end of the sales range, you're growing maybe 3% sequentially in Q4, but your implied margin in Q4 at the high end of the margin guide for the full year, I think the Q4 margin is around 49%, which is down from Q3 despite the implied higher sales.
So just wondering how to think about the drivers here for the margin specifically. Maybe it's visibility, maybe it's a degree of caution, but any commentary there would be helpful. And then I have a follow-up.
Thank you for the question. So basically, if you see the profitability guideline or trend we show it, this is a full year profitability that is not in a decrease compared to Q3 because you should remember that Q1 was a much lower profitability on the EBITDA and then you have to accumulate all the profit of the year.
So we expect for the moment to have Q4 in a range between second quarter and third quarter revenue. We don't know yet which will be the guideline for the order backlogs we will see in Q4, but we expect that in a range between Q3 and Q2 2026. So if the range will be that, we will have a similar profitability equal to the same quarters we have just passed.
There could be some small dilution in the second part of the year, but not significant. In general, the current mix of customer we expect in the second part of the year will be more addressed with higher agency fees or distribution fee that could impact a bit on the profitability.
There will be some probably additional labor award for our colleagues, depending on the results that will be achieved. There will be some R&D and SG&A extra charge related to the Chinese factory ramp-up, especially -- so as you know, we are building a new factory in China to serve the domestic market. And this is ongoing and the vast majority of the expenses for the ramp-up are expected in the second part of the year, so Q3 and Q4. We talk about EUR 3 million to EUR 4 million ramp-up cost in the second part of the year.
So all these elements combined together can give you a very small dilution on the profitability, but the profitability overall across the year will be consistent with the second quarter with the level of revenue of the second quarter and consistently Q3 with the level of revenues of Q3.
Brilliant. Just secondly, wondering if you have any update on the custom ASIC market share or any further engagements with customers. And with these new markets like ASICs, HBM, silicon photonics becoming more material, I guess, in '27, maybe '28, how should we think about the potential for margin dilution or margin gains from these new products versus maybe what you're doing today in the AI GPU, I assume is driving the margin today?
Let me answer from the financial standpoint, and then I'll leave the floor to Stefano. From a financial standpoint and profitability, we do not expect to have any dilution on this product unless maybe for the initial ramp-up of the industrialization.
As Stefano mentioned before, for example, silicon photonics is still on a lab phase. So the cost is higher and the profitability is lower, but we talk about very little volumes. Other mass volumes, we do not expect any dilution on profitability in any of our products.
And I would add that especially for AI products, we are still investing, developing and improving our technologies. So we always -- basically, every generation of GPU also, we update our technology, the new generation of technology, probing technology. So typically, it's the -- our model for profitability is very good. We -- it's not the same product. It's also an updated product or even completely new product. We need to address different challenges year-over-year.
The power of this chip is becoming very, very high. So there are other challenges we need to address. And this is a very good opportunity because can -- as said by Stefano, this can give us the chance to be pretty stable in the profitability, even grow even more with new technologies.
For market share, being --- for, I would say, we're not -- we prefer not to give exactly the percentage of each segment. I can tell you, by the way, that the AI is all of this the mix of products related to AI, I mean GPU, CPU, ASICs more than 50% of our total revenue. So it's very healthy. We are growing. We are -- I mean the numbers are there to see. It's our record quarter and Q3 even more. So we -- I can definitely tell you that we are leader in the market. We have a very strong position, very strong market share in each segment.
Brilliant. Maybe if I could just add one quick question to my 2 questions. Just touching on the question earlier around CapEx beyond Q1 '27. Obviously, you raised to EUR 350 million out to Q1 '27. Are you thinking about going beyond this currently beyond the 140% capacity increase? I assume you're speaking to your customers about '27, '28, maybe forecast even beyond that. So I'm just wondering about CapEx beyond the Q1 '27.
Thank you. This is another very, very key point for Technoprobe. We, of course, have a lot of conversation with our customers. We know -- everybody knows that everyone is investing in capacity, so not only in testing space, but also in the semiconductor industry in general. So we do not give up on investments. So the big investment we are doing right now will allow us to serve the current production, the current demand we have now in our estimates.
What we expect on 2027 and '28 is to make another round of investment, significant round of investments. The amount and the timing of this new CapEx investment is still to be discussed and approved by the Board. But for sure, it will be interesting to see what we will be able to deploy for 2027 and '28. So of course, the capacity will increase even further in the next couple of years. And thanks also not only to the new investment, but to the increase of internal efficiencies.
Yes. And I want to also say that any -- typically, so our -- the way that we plan this incremental investments and CapEx is not in the reaction mode. I mean we just wait and see what happen. But typically, we get very good feedback from our main customers every quarter. We are in front of them, all the major customers and foundries. And they really tell us what to prepare for the future. So they give us good visibility.
We're not talking about orders or commitment, but pretty good visibility about what to do. So I think this is -- of course, when there will be the next round of investment, we will for sure and we will share with you what we're going to do. But we are, I would say, ahead of the game in order to be prepared for the next wave.
The next question comes from Harry Blaiklock.
First one is just around gross margins. I know they've been very strong. And I wanted to ask specifically how much of that is kind of related to customers shifting over to turnkey solutions? And I guess more broadly on that, are you seeing more customers shifting over to turnkey as testing complexity is increasing?
Turnkey solution is, of course, the most profitable product we can sell to our customers. And it is very, very exposed in the second quarter, especially in terms of percentage on the total of our revenues. We cannot, of course, disclose exactly the percentage of our mix. But for the 2 main customers, that related to GPUs is, of course, the most important portion of our revenue. So this is another reason of our gross margin increase across the quarter.
Yes. And basically, I mean -- but you can see from all our main customers, the announcements that they are making. So about very big -- very, very fast acceleration even starting from this year, I mean, even not expected for them as well.
So what happened is that all these main players were very hungry for capacity. So they would take any capacity available, okay? So the game here was how to grow this capacity as fast as possible. And as you can see, we did a very big jump forward Technoprobe. And I can explain this also, and this was said also in some past calls that a bigger factor here was also the fact that we are very vertically integrated. This helped us a lot to be faster in growing the capacity faster than other players, I would say.
And to explain this, maybe I will -- I can make a very simple example. I mean imagine that Technoprobe as race car and you want to go faster, how you do? Of course, you can modify the car, you can try to do something. But if you own the design of the engine and you are the one developing the software for the engine and all the parts of the car are developed by you, of course, you know what to do and you modify the car the way you want is very quickly, okay? So this is really what is happening.
We own and we develop all the main equipment we use for our production, including the software for the equipment. I mean we develop -- we are very, very vertically integrated. So this allowed us to push on efficiency and use our machines in a much better way. And this you can see a very big jump in efficiency and the profitability. Then of course, to grow even more, you need more equipment, so then more CapEx and so on. But the vertical integration helped us really to move faster than standard other players, let's say.
Got it. So you could say the Ferrari of the probe card world.
Well you said.
It's really important, really. So this was important because right now, every suppliers we see I mean this is in our industry, they are short of capacity. No matter what supplier we are considering can be a PCB supplier or any supplier of machines in semiconductor [indiscernible] typically now is fighting for capacity.
Of course, owning the IP and the design and the machines and so on, it is easier, of course, to do things without relying on suppliers that also they have problems with capacity. So of course, we can do by ourselves, we can push more and be faster. So this was really an important point in our [indiscernible].
Got it. And then I just had one last question, which was on kind of a clarification around the capacity investments that you're completing by Q1. I think you mentioned earlier on the call that it would be a run rate of EUR 1.9 billion annual revenue. I don't know whether I misheard that.
But then I guess, an additional question on that. You're obviously talking about further capacity additions beyond that after Q1. But looking at that initial investment that's ending in Q1, how long would you expect it to take to ramp that to kind of close to full utilization?
Well, when you mentioned 1.9, I want to reiterate the message. This is dollar USD. So this is EUR 1.6, USD 1.9, just to clarify. Utilization, it depends who will answer to you because if you ask to sales, they will say we hope to have 100% utilization. If you ask to production, maybe they will say 80%. So in general, it's not always healthy to have a full utilization. We believe that the utilization will be largely used by the end of Q1. But with the 1.6 run rate, we expect to be able to serve all our main customers, unless something unexpected will happen for, I don't know, HBM adoption or silicon photonics adoption or any other unexpected events so far.
The run rate, the capacity will increase again gradually all over 2027. We have, for the moment, a preliminary plan of investments that will be, of course, disclosed as soon as ready that will increase across the year. So we do not expect -- we are very, very confident that our goals and our plans will be consistent with the demand growth.
We will now move on to Giovanni Selvetti.
Congratulations for the results. I think most of the questions were actually answered. Just maybe a follow-up on the questions from both Alberto and George about the implied Q4 numbers.
If I didn't -- you just say I miss heard previously, I think you mentioned also a difference in the mix in Q4 in terms of sales. And I was wondering if you can kind of provide a difference in the gross margin between CPUs and GPUs, just to have an idea.
Yes, on the mix on sales, as I mentioned, we expect Q4 to have a decrease in terms of GPUs because the big campaigns have been already almost completed in the course of 2026. And then cyclicality will restart at the end of Q4 with the deliveries and revenues restarting in 2027. In the meantime, the shift will be addressed to CPUs, more addressed to CPUs and ASICs for which we don't see any particular difference in gross margin and profitability.
So the complexity of the different product is almost the same for the GPUs and volumes are a bit different because what we have experienced in the first part of the year is that industrialization of probe cards for GPUs have been massive. So you have additional operating leverage when you produce more product of the same type. We do not expect to have this similar mix on the last part of the year. So we expect same volumes in general, but composed by more designs, more projects.
So that's why the profitability overall could be -- not overall the profitability -- sorry, the operating leverage could be a little affected. But this is largely expected in our model, and this is also guided an increase at the fiscal year overall gross margin up to 200 basis points on average despite this cyclicality. So for us, it's a very, very encouraging second part of the year.
I see that we have a follow-up question from Oliver Wong.
Just wanted to piggyback on -- you guys sounded pretty confident on continuing to increase capacity. And I was wondering if maybe you could share a little teaser on what's driving that? Obviously, GPU volumes continue to be strong, but out of the emerging opportunities, would you be able to say are there any particular ones, anything in customer conversations that's giving you that confidence to continue to expand capacity?
So what is driving -- is the AI growth that is really still predicted very, very strong, of course, and this is not only -- so the expectation, I mean, we get is not only a higher number of chip to be tested, but with a longer also test time. And this is valid for GPU, CPUs, all the type of AI devices will grow in number of volumes to be tested and also in test intensity. So this is really what is driving the growth of this market. I don't know if this was the question.
Thank you, Oliver. So as we have no hands up at the moment, I will now give the word back to the speakers for any final comments before bringing this presentation to a close. Thank you.
Thank you for -- everyone for joining us tonight. And we were very happy to announce this record quarter. And we hope to see -- to hear from you the next call will be, we think, a very good call. So bye.
Thank you.
Thank you. This presentation will now come to a close.
Transkripte auf Deutsch freischalten
- Alle Event Transkripte auf Deutsch
- Sofortige Übersetzung
- KI-Zusammenfassungen für die wichtigsten Insights
Technoprobe — Q2 2026 Earnings Call
Finanzdaten von Technoprobe
Umsatz
Der Umsatz stellt die Summe aller Einnahmen eines Unternehmens z. B. für dessen Produkte oder Dienstleistungen dar.
Umsatz (TTM) einfach erklärtDirekte Kosten
Direkte Kosten sind die Kosten, die direkt im Zusammenhang mit der Herstellung des Produkts oder der Dienstleistung entstehen.
Bruttoertrag
Der Bruttoertrag gibt an, wie viel vom Umsatz nach Abzug der direkten Herstellkosten im Unternehmen verbleibt. Berechnet man den prozentualen Anteil vom Umsatz, spricht man von der Bruttomarge (engl. Gross Margin).
Brutto Marge einfach erklärtVertriebs- und Verwaltungskosten
Die Vertriebs- & Verwaltungskosten (engl. Selling, General & Administrative expenses, kurz SG&A) beinhalten alle Aufwände für Marketing und den Verkauf sowie die allgemeine Verwaltung des Unternehmens.
Forschungs- und Entwicklungskosten
Die Forschungs- und Entwicklungskosten (engl. research & development costs, kurz R&D) geben Auskunft darüber, wie viel das Unternehmen in die Forschung und die Entwicklung seiner Produkte investiert. Vor allem prozentual vom Umsatz und im Vergleich zu direkten Wettbewerbern sind die Kosten interessant.
EBITDA
Das EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) ist der Gewinn des Unternehmens vor Zinsen, Steuern und Abschreibungen. Berechnet man den prozentualen Anteil vom Umsatz, spricht man von der EBITDA-Marge.
Abschreibungen
Abschreibungen stellen Wertminderungen von Vermögensgegenständen des Unternehmens dar (z.B. durch Abnutzung von Maschinen).
EBIT (Operatives Ergebnis)
Das EBIT (engl. Earnings Before Interest and Taxes) ist der Gewinn des Unternehmens vor Zinsen und Steuern, das auch als operatives Ergebnis bezeichnet wird. Berechnet man den prozentualen Anteil vom Umsatz, spricht man von
der EBIT-Marge.
Nettogewinn
Der Nettogewinn stellt den Gewinn oder Verlust nach Abzug aller Kosten dar.
Nettogewinn einfach erklärtaktien.guide Premium
| Jun '26 |
+/-
%
|
||
| Umsatz | 767 767 |
22 %
22 %
100 %
|
|
| - Direkte Kosten | 388 388 |
10 %
10 %
51 %
|
|
| Bruttoertrag | 378 378 |
38 %
38 %
49 %
|
|
| - Vertriebs- und Verwaltungskosten | 85 85 |
11 %
11 %
11 %
|
|
| - Forschungs- und Entwicklungskosten | 49 49 |
2 %
2 %
6 %
|
|
| EBITDA | 243 243 |
91 %
91 %
32 %
|
|
| - Abschreibungen | 11 11 |
47 %
47 %
1 %
|
|
| EBIT (Operatives Ergebnis) EBIT | 233 233 |
117 %
117 %
30 %
|
|
| Nettogewinn | 206 206 |
194 %
194 %
27 %
|
|
Angaben in Millionen EUR.
Nichts mehr verpassen! Wir senden Dir alle News zur Technoprobe-Aktie direkt und kostenlos in Deine Mailbox.
Auf Wunsch erhältst Du jeden Morgen pünktlich zum Frühstück eine E-Mail, die alle für Dich relevanten Aktien-News enthält.
Technoprobe Aktie News
Firmenprofil
Technoprobe SpA befasst sich mit der Entwicklung, Konstruktion und Herstellung von Prüfkarten, die zum Testen von Nicht-Speicher-Halbleitern oder System-on-Chip-Halbleitern verwendet werden. Das Unternehmen produziert Halbleiter und bietet Mikroelektronik an, wobei es Testlösungen für Chips und Prüfkarten für verschiedene Technologiemarken entwickelt. Das Unternehmen ist ein technologisches Zentrum für Forschung und Innovation im Bereich Halbleiter. Das Unternehmen ist weltweit tätig.
aktien.guide Premium
| Hauptsitz | Italien |
| CEO | Mr. Felici |
| Mitarbeiter | 3.238 |
| Webseite | www.technoprobe.com |


